| Year |
Citation |
Score |
| 2020 |
Harnoss JM, Le Thomas A, Reichelt M, Guttman O, Wu TD, Marsters SA, Shemorry A, Lawrence DA, Kan D, Segal E, Merchant M, Totpal K, Crocker LM, Mesh K, Dohse M, ... ... Ashkenazi A, et al. IRE1α disruption in triple-negative breast cancer cooperates with anti-angiogenic therapy by reversing ER stress adaptation and remodeling the tumor microenvironment. Cancer Research. PMID 32265225 DOI: 10.1158/0008-5472.Can-19-3108 |
0.372 |
|
| 2020 |
Lam M, Marsters SA, Ashkenazi A, Walter P. Misfolded proteins bind and activate death receptor 5 to induce apoptosis during unresolved endoplasmic reticulum stress. Elife. 9. PMID 31904339 DOI: 10.7554/Elife.52291 |
0.428 |
|
| 2019 |
Shemorry A, Harnoss JM, Guttman O, Marsters SA, Kőműves LG, Lawrence DA, Ashkenazi A. Caspase-mediated cleavage of IRE1 controls apoptotic cell commitment during endoplasmic reticulum stress. Elife. 8. PMID 31453810 DOI: 10.7554/Elife.47084 |
0.369 |
|
| 2019 |
Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Lu M, Chen YA, Qing J, Totpal K, Kan D, Segal E, Merchant M, Reichelt M, Ackerly Wallweber H, Wang W, ... ... Ashkenazi A, et al. Disruption of IRE1α through its kinase domain attenuates multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America. PMID 31371506 DOI: 10.1073/Pnas.1906999116 |
0.331 |
|
| 2019 |
Yang Y, Yeh SH, Madireddi S, Matochko WL, Gu C, Pacheco Sanchez P, Ultsch M, de Leon Boenig G, Harris SF, Leonard B, Scales SJ, Zhu J, Christensen E, Hang JQ, Brezski RJ, ... ... Ashkenazi A, et al. Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members. Mabs. PMID 31156033 DOI: 10.1080/19420862.2019.1625662 |
0.406 |
|
| 2019 |
Lam M, Marsters SA, Ashkenazi A, Walter P. Author response: Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress Elife. DOI: 10.7554/Elife.52291.Sa2 |
0.397 |
|
| 2019 |
Shemorry A, Harnoss JM, Guttman O, Marsters SA, Kőműves LG, Lawrence DA, Ashkenazi A. Author response: Caspase-mediated cleavage of IRE1 controls apoptotic cell commitment during endoplasmic reticulum stress Elife. DOI: 10.7554/Elife.47084.015 |
0.336 |
|
| 2018 |
Chang TK, Lawrence DA, Lu M, Tan J, Harnoss JM, Marsters SA, Liu P, Sandoval W, Martin SE, Ashkenazi A. Coordination between Two Branches of the Unfolded Protein Response Determines Apoptotic Cell Fate. Molecular Cell. 71: 629-636.e5. PMID 30118681 DOI: 10.1016/J.Molcel.2018.06.038 |
0.381 |
|
| 2018 |
Lam M, Lawrence DA, Ashkenazi A, Walter P. Confirming a critical role for death receptor 5 and caspase-8 in apoptosis induction by endoplasmic reticulum stress. Cell Death and Differentiation. PMID 29991746 DOI: 10.1038/S41418-018-0155-Y |
0.399 |
|
| 2017 |
Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nature Reviews. Drug Discovery. PMID 28209992 DOI: 10.1038/Nrd.2016.253 |
0.375 |
|
| 2016 |
Zuch de Zafra CL, Ashkenazi A, Darbonne WC, Cheu M, Totpal K, Ortega S, Flores H, Walker MD, Kabakoff B, Lum BL, Mounho-Zamora BJ, Marsters SA, Dybdal NO. Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey. Cell Death & Disease. 7: e2338. PMID 27512959 DOI: 10.1038/Cddis.2016.241 |
0.403 |
|
| 2016 |
Anania VG, Yu K, Gnad F, Pferdehirt RR, Li H, Ma T, Jeon D, Fortelny N, Forrest W, Ashkenazi A, Overall CM, Lill JR. Uncovering a dual regulatory role for caspases during endoplasmic reticulum stress-induced cell death. Molecular & Cellular Proteomics : McP. PMID 27125827 DOI: 10.1074/Mcp.M115.055376 |
0.349 |
|
| 2015 |
Nair PM, Ngu H, Torres E, Marsters S, Lawrence DA, Stephan JP, Komuves L, Ashkenazi A. Membrane display and functional analysis of juxtacrine ligand-receptor signaling. Biotechniques. 59: 231-40. PMID 26458551 DOI: 10.2144/000114342 |
0.406 |
|
| 2015 |
Yin Y, Djakovic S, Marsters S, Tien J, Peng J, Tremayne J, Lee G, Neve RM, Wu Y, Merchant M, Ashkenazi A, Carter PJ. Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Anti-tumor Activity. Molecular Cancer Therapeutics. PMID 26269606 DOI: 10.1158/1535-7163.Mct-14-1050 |
0.691 |
|
| 2015 |
Chen TT, Filvaroff E, Peng J, Marsters S, Jubb A, Koeppen H, Merchant M, Ashkenazi A. MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation. Ebiomedicine. 2: 406-20. PMID 26137585 DOI: 10.1016/J.Ebiom.2015.03.021 |
0.33 |
|
| 2015 |
Nair PM, Flores H, Gogineni A, Marsters S, Lawrence DA, Kelley RF, Ngu H, Sagolla M, Komuves L, Bourgon R, Settleman J, Ashkenazi A. Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display. Proceedings of the National Academy of Sciences of the United States of America. 112: 5679-84. PMID 25902490 DOI: 10.1073/Pnas.1418962112 |
0.437 |
|
| 2015 |
Petersen SL, Chen TT, Lawrence DA, Marsters SA, Gonzalvez F, Ashkenazi A. TRAF2 is a biologically important necroptosis suppressor. Cell Death and Differentiation. PMID 25882049 DOI: 10.1038/Cdd.2015.35 |
0.428 |
|
| 2015 |
Ashkenazi A. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions. The Journal of Clinical Investigation. 125: 487-9. PMID 25642709 DOI: 10.1172/Jci80420 |
0.457 |
|
| 2014 |
Ashkenazi A, Salvesen G. Regulated cell death: signaling and mechanisms. Annual Review of Cell and Developmental Biology. 30: 337-56. PMID 25150011 DOI: 10.1146/Annurev-Cellbio-100913-013226 |
0.414 |
|
| 2014 |
Ashkenazi A, Wells JA, Yuan J. Methods in Enzymology. Regulated cell death part B--necroptotic, autophagic and other non-apoptotic mechanisms. Preface. Methods in Enzymology. 545: xiii. PMID 25065895 DOI: 10.1016/B978-0-12-801430-1.10000-9 |
0.332 |
|
| 2014 |
Lu M, Lawrence DA, Marsters S, Acosta-Alvear D, Kimmig P, Mendez AS, Paton AW, Paton JC, Walter P, Ashkenazi A. Cell death. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science (New York, N.Y.). 345: 98-101. PMID 24994655 DOI: 10.1126/Science.1254312 |
0.385 |
|
| 2014 |
Ashkenazi A, Yuan J, Wells JA. Regulated cell death part A: apoptotic mechanisms. Preface. Methods in Enzymology. 544: xv. PMID 24974300 DOI: 10.1016/B978-0-12-417158-9.10000-7 |
0.361 |
|
| 2014 |
Nair P, Lu M, Petersen S, Ashkenazi A. Apoptosis initiation through the cell-extrinsic pathway. Methods in Enzymology. 544: 99-128. PMID 24974288 DOI: 10.1016/B978-0-12-417158-9.00005-4 |
0.455 |
|
| 2014 |
Fairbrother WJ, Ashkenazi A. Designer proteins to trigger cell death. Cell. 157: 1506-8. PMID 24949963 DOI: 10.1016/J.Cell.2014.06.010 |
0.314 |
|
| 2014 |
Lu M, Marsters S, Ye X, Luis E, Gonzalez L, Ashkenazi A. E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis. Molecular Cell. 54: 987-98. PMID 24882208 DOI: 10.1016/J.Molcel.2014.04.029 |
0.402 |
|
| 2014 |
Newton K, Hildebrand JM, Shen Z, Rodriguez D, Alvarez-Diaz S, Petersen S, Shah S, Dugger DL, Huang C, Auwerx J, Vandenabeele P, Green DR, Ashkenazi A, Dixit VM, Kaiser WJ, et al. Is SIRT2 required for necroptosis? Nature. 506: E4-6. PMID 24572428 DOI: 10.1038/Nature13024 |
0.326 |
|
| 2014 |
Wilson C, Pham T, Ye X, Lin E, Chan S, McNamara E, Neve RM, Belmont L, Koeppen H, Yauch RL, Ashkenazi A, Settleman J. Abstract 693: AXL tyrosine kinase inhibition selectively sensitizes mesenchymal cancer cells to antimitotic agents Cancer Research. 74: 693-693. DOI: 10.1158/1538-7445.Am2014-693 |
0.336 |
|
| 2013 |
Chaudhuri A, Wilson NS, Yang B, Paler Martinez A, Liu J, Zhu C, Bricker N, Couto S, Modrusan Z, French D, Cupp J, Ashkenazi A. Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages. Immunology and Cell Biology. 91: 451-60. PMID 23817579 DOI: 10.1038/Icb.2013.27 |
0.305 |
|
| 2013 |
Lim B, Scicchitano A, Beachler C, Gusani N, Sarwani N, Yang Z, Staveley-O'Carroll K, Ashkenazi A, Portera C, El-Deiry WS. FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer. Cancer Biology & Therapy. 14: 711-9. PMID 23792567 DOI: 10.4161/Cbt.25310 |
0.319 |
|
| 2013 |
Gust KM, McConkey DJ, Awrey S, Hegarty PK, Qing J, Bondaruk J, Ashkenazi A, Czerniak B, Dinney CP, Black PC. Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer. Molecular Cancer Therapeutics. 12: 1245-54. PMID 23657946 DOI: 10.1158/1535-7163.Mct-12-1150 |
0.353 |
|
| 2013 |
Ogasawara A, Tinianow JN, Vanderbilt AN, Gill HS, Yee S, Flores JE, Williams SP, Ashkenazi A, Marik J. ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models. Nuclear Medicine and Biology. 40: 15-22. PMID 23062948 DOI: 10.1016/J.Nucmedbio.2012.09.001 |
0.398 |
|
| 2013 |
Ye X, Yue P, Patel R, Modrusan Z, Settleman J, Ashkenazi A, Yauch RL. Abstract 4463: Activation of FGFR signaling as a mechanism of acquired resistance to erlotinib in EGFR-mutant lung cancer associated with an EMT. Cancer Research. 73: 4463-4463. DOI: 10.1158/1538-7445.Am2013-4463 |
0.317 |
|
| 2012 |
Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan JP, Lill J, Ashkenazi A. TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Molecular Cell. 48: 888-99. PMID 23142077 DOI: 10.1016/J.Molcel.2012.09.031 |
0.431 |
|
| 2012 |
Du X, Wang QR, Chan E, Merchant M, Liu J, French D, Ashkenazi A, Qing J. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. Cancer Research. 72: 5843-55. PMID 23019225 DOI: 10.1158/0008-5472.Can-12-1329 |
0.398 |
|
| 2012 |
Subbiah V, Brown RE, Buryanek J, Trent J, Ashkenazi A, Herbst R, Kurzrock R. Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist. Molecular Cancer Therapeutics. 11: 2541-6. PMID 22914439 DOI: 10.1158/1535-7163.Mct-12-0358 |
0.354 |
|
| 2012 |
Wilson NS, Yang A, Yang B, Couto S, Stern H, Gogineni A, Pitti R, Marsters S, Weimer RM, Singh M, Ashkenazi A. Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth. Cancer Cell. 22: 80-90. PMID 22789540 DOI: 10.1016/J.Ccr.2012.05.014 |
0.39 |
|
| 2012 |
French DM, Lin BC, Wang M, Adams C, Shek T, Hötzel K, Bolon B, Ferrando R, Blackmore C, Schroeder K, Rodriguez LA, Hristopoulos M, Venook R, Ashkenazi A, Desnoyers LR. Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. Plos One. 7: e36713. PMID 22615798 DOI: 10.1371/Journal.Pone.0036713 |
0.314 |
|
| 2012 |
Pham VC, Pitti R, Anania VG, Bakalarski CE, Bustos D, Jhunjhunwala S, Phung QT, Yu K, Forrest WF, Kirkpatrick DS, Ashkenazi A, Lill JR. Complementary proteomic tools for the dissection of apoptotic proteolysis events. Journal of Proteome Research. 11: 2947-54. PMID 22432722 DOI: 10.1021/Pr300035K |
0.387 |
|
| 2012 |
Kasubhai SM, Bendell JC, Kozloff M, Kapp AV, Ashkenazi A, Royer-Joo S, Portera CC. Phase Ib study of dulanermin combined with FOLFIRI (with or without bevacizumab [BV]) in previously treated patients (Pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 30: 3543-3543. DOI: 10.1200/Jco.2012.30.15_Suppl.3543 |
0.324 |
|
| 2011 |
Chaudhuri A, Xie MH, Yang B, Mahapatra K, Liu J, Marsters S, Bodepudi S, Ashkenazi A. Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET. The Journal of Biological Chemistry. 286: 32762-74. PMID 21784853 DOI: 10.1074/Jbc.M111.239384 |
0.329 |
|
| 2011 |
Ikner A, Ashkenazi A. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. The Journal of Biological Chemistry. 286: 21546-54. PMID 21525013 DOI: 10.1074/Jbc.M110.203745 |
0.441 |
|
| 2011 |
Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling. Cell. 145: 92-103. PMID 21458669 DOI: 10.1016/J.Cell.2011.02.023 |
0.346 |
|
| 2011 |
Wilson NS, Yang B, Yang A, Loeser S, Marsters S, Lawrence D, Li Y, Pitti R, Totpal K, Yee S, Ross S, Vernes JM, Lu Y, Adams C, Offringa R, ... ... Ashkenazi A, et al. An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells. Cancer Cell. 19: 101-13. PMID 21251615 DOI: 10.1016/J.Ccr.2010.11.012 |
0.438 |
|
| 2011 |
Kozloff M, Messersmith WA, Kapp AV, Ashkenazi A, Royer-Joo S, Portera CC, Wainberg ZA. Phase Ib study of dulanermin combined with first-line FOLFOX plus bevacizumab (BV) in patients (Pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 29: 3552-3552. DOI: 10.1200/Jco.2012.30.15_Suppl.3552 |
0.317 |
|
| 2011 |
Du X, Li H, Ingalla E, Ross S, French D, Tien J, Ashkenazi A, Qing J. Abstract C63: Targeting FGFR3 with monoclonal antibody impairs bladder cancer growth in vivo. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C63 |
0.349 |
|
| 2010 |
Bagri A, Ashkenazi A. UNCovering the molecular machinery of dependence receptor signaling. Molecular Cell. 40: 851-3. PMID 21172648 DOI: 10.1016/J.Molcel.2010.12.015 |
0.344 |
|
| 2010 |
Yang A, Wilson NS, Ashkenazi A. Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. Current Opinion in Cell Biology. 22: 837-44. PMID 20813513 DOI: 10.1016/J.Ceb.2010.08.001 |
0.418 |
|
| 2010 |
Gonzalvez F, Ashkenazi A. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29: 4752-65. PMID 20531300 DOI: 10.1038/Onc.2010.221 |
0.462 |
|
| 2010 |
Herbst RS, Eckhardt SG, Kurzrock R, Ebbinghaus S, O'Dwyer PJ, Gordon MS, Novotny W, Goldwasser MA, Tohnya TM, Lum BL, Ashkenazi A, Jubb AM, Mendelson DS. Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2839-46. PMID 20458040 DOI: 10.1200/Jco.2009.25.1991 |
0.442 |
|
| 2010 |
Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1587-96. PMID 20179215 DOI: 10.1158/1078-0432.Ccr-09-3108 |
0.328 |
|
| 2010 |
Camidge DR, Herbst RS, Gordon MS, Eckhardt SG, Kurzrock R, Durbin B, Ing J, Tohnya TM, Sager J, Ashkenazi A, Bray G, Mendelson D. A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1256-63. PMID 20145186 DOI: 10.1158/1078-0432.Ccr-09-1267 |
0.391 |
|
| 2010 |
Eimon PM, Ashkenazi A. The zebrafish as a model organism for the study of apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 15: 331-49. PMID 20033783 DOI: 10.1007/S10495-009-0432-9 |
0.388 |
|
| 2009 |
Varfolomeev E, Alicke B, Elliott JM, Zobel K, West K, Wong H, Scheer JM, Ashkenazi A, Gould SE, Fairbrother WJ, Vucic D. X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonists. The Journal of Biological Chemistry. 284: 34553-60. PMID 19854829 DOI: 10.1074/Jbc.M109.040139 |
0.486 |
|
| 2009 |
Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, Ashkenazi A. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell. 137: 721-35. PMID 19427028 DOI: 10.1016/J.Cell.2009.03.015 |
0.417 |
|
| 2009 |
Qing J, Du X, Chen Y, Chan P, Li H, Wu P, Marsters S, Stawicki S, Tien J, Totpal K, Ross S, Stinson S, Dornan D, French D, Wang QR, ... ... Ashkenazi A, et al. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. The Journal of Clinical Investigation. 119: 1216-29. PMID 19381019 DOI: 10.1172/Jci38017 |
0.413 |
|
| 2009 |
Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunology. 10: 348-55. PMID 19295631 DOI: 10.1038/Ni.1714 |
0.375 |
|
| 2008 |
Jin H, Yang R, Ross J, Fong S, Carano R, Totpal K, Lawrence D, Zheng Z, Koeppen H, Stern H, Schwall R, Ashkenazi A. Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7733-40. PMID 19047100 DOI: 10.1158/1078-0432.Ccr-08-0670 |
0.366 |
|
| 2008 |
Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nature Reviews. Drug Discovery. 7: 1001-12. PMID 18989337 DOI: 10.1038/Nrd2637 |
0.478 |
|
| 2008 |
Shang Y, Mao Y, Batson J, Scales SJ, Phillips G, Lackner MR, Totpal K, Williams S, Yang J, Tang Z, Modrusan Z, Tan C, Liang WC, Tsai SP, Vanderbilt A, ... ... Ashkenazi A, et al. Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake. Molecular Cancer Therapeutics. 7: 2599-608. PMID 18790743 DOI: 10.1158/1535-7163.Mct-07-2401 |
0.383 |
|
| 2008 |
Ashkenazi A, Holland P, Eckhardt SG. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3621-30. PMID 18640940 DOI: 10.1200/Jco.2007.15.7198 |
0.466 |
|
| 2008 |
Ashkenazi A, Herbst RS. To kill a tumor cell: the potential of proapoptotic receptor agonists. The Journal of Clinical Investigation. 118: 1979-90. PMID 18523647 DOI: 10.1172/Jci34359 |
0.431 |
|
| 2008 |
Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine & Growth Factor Reviews. 19: 325-31. PMID 18495520 DOI: 10.1016/J.Cytogfr.2008.04.001 |
0.473 |
|
| 2008 |
Adams C, Totpal K, Lawrence D, Marsters S, Pitti R, Yee S, Ross S, Deforge L, Koeppen H, Sagolla M, Compaan D, Lowman H, Hymowitz S, Ashkenazi A. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death and Differentiation. 15: 751-61. PMID 18219321 DOI: 10.1038/Sj.Cdd.4402306 |
0.332 |
|
| 2008 |
Desnoyers LR, Pai R, Ferrando RE, Hötzel K, Le T, Ross J, Carano R, D'Souza A, Qing J, Mohtashemi I, Ashkenazi A, French DM. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene. 27: 85-97. PMID 17599042 DOI: 10.1038/Sj.Onc.1210623 |
0.347 |
|
| 2008 |
Ashkenazi A, Wagner K, Punnnoose E, Lawrence D, Pitti R, Amler L. Identification of potentially predictive biomarkers for tumor sensitivity to proapoptotic receptor agonists Journal of Clinical Oncology. 26: 14505-14505. DOI: 10.1200/Jco.2008.26.15_Suppl.14505 |
0.457 |
|
| 2007 |
Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF, Totpal K, Huw L, Katta V, Cavet G, Hymowitz SG, Amler L, ... Ashkenazi A, et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nature Medicine. 13: 1070-7. PMID 17767167 DOI: 10.1038/Nm1627 |
0.393 |
|
| 2007 |
Daniel D, Yang B, Lawrence DA, Totpal K, Balter I, Lee WP, Gogineni A, Cole MJ, Yee SF, Ross S, Ashkenazi A. Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts. Blood. 110: 4037-46. PMID 17724141 DOI: 10.1182/Blood-2007-02-076075 |
0.453 |
|
| 2007 |
Naumann U, Bähr O, Wolburg H, Altenberend S, Wick W, Liston P, Ashkenazi A, Weller M. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice. Gene Therapy. 14: 147-61. PMID 16957768 DOI: 10.1038/Sj.Gt.3302845 |
0.328 |
|
| 2007 |
Yee L, Fanale M, Dimick K, Calvert S, Robins C, Ing J, Novotny W, Ashkenazi A, Burris H. A phase IB safety and pharmacokinetic (PK) study of recombinant human Apo2L/TRAIL in combination with rituximab in patients with low-grade non-Hodgkin lymphoma Journal of Clinical Oncology. 25: 8078-8078. DOI: 10.1200/Jco.2007.25.18_Suppl.8078 |
0.437 |
|
| 2007 |
Naumann U, Bähr O, Wolburg H, Altenberend S, Wick W, Liston P, Ashkenazi A, Weller M. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice (Gene Therapy (2007) vol. 14 (147-161) 10.1038/sj.gt.3302845) Gene Therapy. 14: 1434-1437. DOI: 10.1038/Sj.Gt.3303002 |
0.323 |
|
| 2006 |
Eimon PM, Kratz E, Varfolomeev E, Hymowitz SG, Stern H, Zha J, Ashkenazi A. Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death and Differentiation. 13: 1619-30. PMID 16888647 DOI: 10.1038/Sj.Cdd.4402015 |
0.459 |
|
| 2006 |
Kratz E, Eimon PM, Mukhyala K, Stern H, Zha J, Strasser A, Hart R, Ashkenazi A. Functional characterization of the Bcl-2 gene family in the zebrafish. Cell Death and Differentiation. 13: 1631-40. PMID 16888646 DOI: 10.1038/Sj.Cdd.4402016 |
0.333 |
|
| 2006 |
Li B, Russell SJ, Compaan DM, Totpal K, Marsters SA, Ashkenazi A, Cochran AG, Hymowitz SG, Sidhu SS. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. Journal of Molecular Biology. 361: 522-36. PMID 16859704 DOI: 10.1016/J.Jmb.2006.06.042 |
0.432 |
|
| 2006 |
Austin CD, Lawrence DA, Peden AA, Varfolomeev EE, Totpal K, De Mazière AM, Klumperman J, Arnott D, Pham V, Scheller RH, Ashkenazi A. Death-receptor activation halts clathrin-dependent endocytosis. Proceedings of the National Academy of Sciences of the United States of America. 103: 10283-8. PMID 16801533 DOI: 10.1073/Pnas.0604044103 |
0.441 |
|
| 2005 |
Hymowitz SG, Ashkenazi A. Toward small-molecule agonists of TNF receptors. Nature Chemical Biology. 1: 353-4. PMID 16370368 DOI: 10.1038/Nchembio1205-353 |
0.352 |
|
| 2005 |
Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D, Ashkenazi A. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. The Journal of Biological Chemistry. 280: 40599-608. PMID 16227629 DOI: 10.1074/Jbc.M509560200 |
0.392 |
|
| 2005 |
Cretney E, McQualter JL, Kayagaki N, Yagita H, Bernard CC, Grewal IS, Ashkenazi A, Smyth MJ. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunology and Cell Biology. 83: 511-9. PMID 16174101 DOI: 10.1111/J.1440-1711.2005.01358.X |
0.358 |
|
| 2005 |
Sharp DA, Lawrence DA, Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. The Journal of Biological Chemistry. 280: 19401-9. PMID 15760909 DOI: 10.1074/Jbc.M413962200 |
0.426 |
|
| 2005 |
Kelley RF, Totpal K, Lindstrom SH, Mathieu M, Billeci K, Deforge L, Pai R, Hymowitz SG, Ashkenazi A. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. The Journal of Biological Chemistry. 280: 2205-12. PMID 15520016 DOI: 10.1074/Jbc.M410660200 |
0.479 |
|
| 2004 |
Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, Mayer EG, Yu H, Pardoll DM, Ashkenazi A, Bedi A. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Cancer Research. 64: 9105-14. PMID 15604280 DOI: 10.1158/0008-5472.Can-04-2488 |
0.374 |
|
| 2004 |
Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Cancer Research. 64: 4900-5. PMID 15256461 DOI: 10.1158/0008-5472.Can-04-0408 |
0.419 |
|
| 2004 |
Kelley SK, Ashkenazi A. Targeting death receptors in cancer with Apo2L/TRAIL. Current Opinion in Pharmacology. 4: 333-9. PMID 15251125 DOI: 10.1016/J.Coph.2004.02.006 |
0.452 |
|
| 2004 |
Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 116: 491-7. PMID 14980217 DOI: 10.1016/S0092-8674(04)00166-7 |
0.392 |
|
| 2004 |
Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A. APRIL-deficient mice have normal immune system development. Molecular and Cellular Biology. 24: 997-1006. PMID 14729948 DOI: 10.1128/Mcb.24.3.997-1006.2004 |
0.378 |
|
| 2003 |
Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine & Growth Factor Reviews. 14: 337-48. PMID 12787570 DOI: 10.1016/S1359-6101(03)00029-7 |
0.49 |
|
| 2003 |
Miller K, Meng G, Liu J, Hurst A, Hsei V, Wong WL, Ekert R, Lawrence D, Sherwood S, DeForge L, Gaudreault J, Keller G, Sliwkowski M, Ashkenazi A, Presta L. Design, construction, and in vitro analyses of multivalent antibodies. Journal of Immunology (Baltimore, Md. : 1950). 170: 4854-61. PMID 12728922 DOI: 10.4049/Jimmunol.170.9.4854 |
0.364 |
|
| 2003 |
LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death and Differentiation. 10: 66-75. PMID 12655296 DOI: 10.1038/Sj.Cdd.4401187 |
0.474 |
|
| 2002 |
Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nature Reviews. Cancer. 2: 420-30. PMID 12189384 DOI: 10.1038/Nrc821 |
0.438 |
|
| 2002 |
Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. The American Journal of Pathology. 161: 643-54. PMID 12163389 DOI: 10.1016/S0002-9440(10)64220-4 |
0.433 |
|
| 2002 |
LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nature Medicine. 8: 274-81. PMID 11875499 DOI: 10.1038/Nm0302-274 |
0.395 |
|
| 2001 |
Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. The Journal of Biological Chemistry. 276: 46639-46. PMID 11583996 DOI: 10.1074/Jbc.M105102200 |
0.426 |
|
| 2001 |
Wang H, Marsters SA, Baker T, Chan B, Lee WP, Fu L, Tumas D, Yan M, Dixit VM, Ashkenazi A, Grewal IS. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nature Immunology. 2: 632-7. PMID 11429548 DOI: 10.1038/89782 |
0.344 |
|
| 2001 |
Chuntharapai A, Dodge K, Grimmer K, Schroeder K, Marsters SA, Koeppen H, Ashkenazi A, Kim KJ. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. Journal of Immunology (Baltimore, Md. : 1950). 166: 4891-8. PMID 11290766 DOI: 10.4049/Jimmunol.166.8.4891 |
0.454 |
|
| 2001 |
Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A, Weller M. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Research. 61: 2759-65. PMID 11289159 |
0.303 |
|
| 2000 |
Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Current Biology : Cb. 10: 785-8. PMID 10898980 DOI: 10.1016/S0960-9822(00)00566-2 |
0.392 |
|
| 2000 |
Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 12: 611-20. PMID 10894161 DOI: 10.1016/S1074-7613(00)80212-5 |
0.466 |
|
| 2000 |
Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nature Immunology. 1: 37-41. PMID 10881172 DOI: 10.1038/76889 |
0.357 |
|
| 2000 |
Hymowitz SG, O'Connell MP, Ultsch MH, Hurst A, Totpal K, Ashkenazi A, de Vos AM, Kelley RF. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry. 39: 633-40. PMID 10651627 DOI: 10.1021/Bi992242L |
0.406 |
|
| 1999 |
Roth W, Isenmann S, Naumann U, Kügler S, Bähr M, Dichgans J, Ashkenazi A, Weller M. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochemical and Biophysical Research Communications. 265: 479-83. PMID 10558893 DOI: 10.1006/Bbrc.1999.1693 |
0.354 |
|
| 1999 |
Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Molecular Cell. 4: 563-71. PMID 10549288 DOI: 10.1016/S1097-2765(00)80207-5 |
0.406 |
|
| 1999 |
Marsters SA, Pitti RA, Sheridan JP, Ashkenazi A. Control of apoptosis signaling by Apo2 ligand. Recent Progress in Hormone Research. 54: 225-34. PMID 10548878 |
0.391 |
|
| 1999 |
Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine. 11: 664-72. PMID 10479402 DOI: 10.1006/Cyto.1999.0489 |
0.338 |
|
| 1999 |
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. The Journal of Clinical Investigation. 104: 155-62. PMID 10411544 DOI: 10.1172/Jci6926 |
0.405 |
|
| 1999 |
Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Current Opinion in Cell Biology. 11: 255-60. PMID 10209153 DOI: 10.1016/S0955-0674(99)80034-9 |
0.454 |
|
| 1999 |
Gurney AL, Marsters SA, Huang RM, Pitti RM, Mark DT, Baldwin DT, Gray AM, Dowd AD, Brush AD, Heldens AD, Schow AD, Goddard AD, Wood WI, Baker KP, Godowski PJ, ... Ashkenazi A, et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Current Biology : Cb. 9: 215-8. PMID 10074428 DOI: 10.1016/S0960-9822(99)80093-1 |
0.416 |
|
| 1998 |
Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, ... ... Ashkenazi A, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396: 699-703. PMID 9872321 DOI: 10.1038/25387 |
0.454 |
|
| 1998 |
Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science (New York, N.Y.). 281: 1305-8. PMID 9721089 DOI: 10.1126/Science.281.5381.1305 |
0.418 |
|
| 1998 |
Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. APO2 ligand: a novel lethal weapon against malignant glioma? Febs Letters. 427: 124-8. PMID 9613612 DOI: 10.1016/S0014-5793(98)00409-8 |
0.447 |
|
| 1998 |
Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Current Biology : Cb. 8: 525-8. PMID 9560343 DOI: 10.1016/S0960-9822(98)70204-0 |
0.447 |
|
| 1997 |
Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Current Biology : Cb. 7: 1003-6. PMID 9382840 DOI: 10.1016/S0960-9822(06)00422-2 |
0.47 |
|
| 1997 |
Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (New York, N.Y.). 277: 818-21. PMID 9242611 DOI: 10.1126/Science.277.5327.818 |
0.465 |
|
| 1997 |
Ashkenazi A, Chamow SM. Immunoadhesins as research tools and therapeutic agents. Current Opinion in Immunology. 9: 195-200. PMID 9099788 DOI: 10.1016/S0952-7915(97)80135-5 |
0.321 |
|
| 1996 |
Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Current Biology : Cb. 6: 1669-76. PMID 8994832 DOI: 10.1016/S0960-9822(02)70791-4 |
0.428 |
|
| 1996 |
Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Current Biology : Cb. 6: 750-2. PMID 8793301 DOI: 10.1016/S0960-9822(09)00456-4 |
0.422 |
|
| 1996 |
Chamow SM, Ashkenazi A. Immunoadhesins: principles and applications. Trends in Biotechnology. 14: 52-60. PMID 8746117 DOI: 10.1016/0167-7799(96)80921-8 |
0.308 |
|
| 1996 |
Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. The Journal of Biological Chemistry. 271: 12687-90. PMID 8663110 DOI: 10.1074/Jbc.271.22.12687 |
0.391 |
|
| 1995 |
Oksenberg D, Havlik S, Peroutka SJ, Ashkenazi A. The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificity. Journal of Neurochemistry. 64: 1440-7. PMID 7891070 DOI: 10.1046/J.1471-4159.1995.64041440.X |
0.344 |
|
| 1995 |
Ashkenazi A, Chamow SM. Immunoadhesins: An Alternative to Human Monoclonal Antibodies Methods. 8: 104-115. DOI: 10.1006/Meth.1995.9996 |
0.341 |
|
| 1994 |
Jin H, Yang R, Marsters SA, Bunting SA, Wurm FM, Chamow SM, Ashkenazi A. Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. The Journal of Infectious Diseases. 170: 1323-6. PMID 7963738 DOI: 10.1093/Infdis/170.5.1323 |
0.32 |
|
| 1992 |
Oksenberg D, Marsters SA, O'Dowd BF, Jin H, Havlik S, Peroutka SJ, Ashkenazi A. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature. 360: 161-3. PMID 1436092 DOI: 10.1038/360161A0 |
0.342 |
|
| 1991 |
Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proceedings of the National Academy of Sciences of the United States of America. 88: 10535-9. PMID 1660140 DOI: 10.1073/Pnas.88.23.10535 |
0.328 |
|
| 1989 |
Ashkenazi A, Ramachandran J, Capon DJ. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature. 340: 146-50. PMID 2739737 DOI: 10.1038/340146A0 |
0.324 |
|
| 1989 |
Ramachandran J, Peralta EG, Ashkenazi A, Winslow JW, Capon DJ. The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 10: 54-7. PMID 2655586 DOI: 10.1002/Bies.950100205 |
0.346 |
|
| 1989 |
Ashkenazi A, Peralta EG, Winslow JW, Ramachandran J, Capon DJ. Functionally distinct G proteins selectively couple different receptors to PI hydrolysis in the same cell. Cell. 56: 487-93. PMID 2492452 DOI: 10.1016/0092-8674(89)90251-1 |
0.343 |
|
| 1988 |
Ashkenazi A, Peralta EG, Winslow JW, Ramachandran J, Capon DJ. Functional role of muscarinic acetylcholine receptor subtype diversity. Cold Spring Harbor Symposia On Quantitative Biology. 53: 263-72. PMID 3254774 DOI: 10.1101/Sqb.1988.053.01.033 |
0.303 |
|
| 1988 |
Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature. 334: 434-7. PMID 2841607 DOI: 10.1038/334434A0 |
0.375 |
|
| 1987 |
Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. The Embo Journal. 6: 3923-9. PMID 3443095 DOI: 10.1002/J.1460-2075.1987.Tb02733.X |
0.356 |
|
| 1987 |
Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, Capon DJ. Primary structure and biochemical properties of an M2 muscarinic receptor. Science (New York, N.Y.). 236: 600-5. PMID 3107123 DOI: 10.1126/Science.3107123 |
0.338 |
|
| 1987 |
Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, Capon DJ, Ramachandran J. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science (New York, N.Y.). 238: 672-5. PMID 2823384 DOI: 10.1126/Science.2823384 |
0.356 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2001 |
Pollack IF, Erff M, Ashkenazi A. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 1362-9. PMID 11350907 |
0.299 |
|
| 1995 |
Marsters SA, Pennica D, Bach E, Schreiber RD, Ashkenazi A. Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proceedings of the National Academy of Sciences of the United States of America. 92: 5401-5. PMID 7777519 DOI: 10.1073/Pnas.92.12.5401 |
0.297 |
|
| 1995 |
Chamow SM, Zhang D, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. Journal of Hematotherapy. 4: 439-46. PMID 8581382 DOI: 10.1089/Scd.1.1995.4.439 |
0.295 |
|
| 1994 |
Beck JT, Marsters SA, Harris RJ, Carter P, Ashkenazi A, Chamow SM. Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage. Molecular Immunology. 31: 1335-44. PMID 7997245 DOI: 10.1016/0161-5890(94)90052-3 |
0.29 |
|
| 1990 |
Chamow SM, Peers DH, Byrn RA, Mulkerrin MG, Harris RJ, Wang WC, Bjorkman PJ, Capon DJ, Ashkenazi A. Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry. 29: 9885-91. PMID 2125484 DOI: 10.1021/Bi00494A019 |
0.283 |
|
| 1990 |
Ashkenazi A, Presta LG, Marsters SA, Camerato TR, Rosenthal KA, Fendly BM, Capon DJ. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proceedings of the National Academy of Sciences of the United States of America. 87: 7150-4. PMID 2402498 DOI: 10.1073/Pnas.87.18.7150 |
0.279 |
|
| 2012 |
Wilson NS, Yang B, Morelli AB, Koernig S, Yang A, Loeser S, Airey D, Provan L, Hass P, Braley H, Couto S, Drane D, Boyle J, Belz GT, Ashkenazi A, et al. ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway. Immunology and Cell Biology. 90: 540-52. PMID 21894173 DOI: 10.1038/Icb.2011.71 |
0.275 |
|
| 1993 |
Pennica D, Lam VT, Weber RF, Kohr WJ, Basa LJ, Spellman MW, Ashkenazi A, Shire SJ, Goeddel DV. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry. 32: 3131-8. PMID 8384489 DOI: 10.1021/Bi00063A027 |
0.275 |
|
| 2005 |
Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A. TWEAK attenuates the transition from innate to adaptive immunity. Cell. 123: 931-44. PMID 16325585 DOI: 10.1016/J.Cell.2005.09.022 |
0.274 |
|
| 2007 |
Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier-Lavigne M, Bolon B, French DM, Ashkenazi A. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. Plos One. 2: e575. PMID 17593974 DOI: 10.1371/Journal.Pone.0000575 |
0.272 |
|
| 2023 |
Castellano BM, Tang D, Marsters S, Lam C, Liu P, Rose CM, Sandoval W, Ashkenazi A, Snedecor B, Misaghi S. Activation of the PERK branch of the unfolded protein response during production reduces specific productivity in CHO cells via downregulation of PDGFRa and IRE1a signaling. Biotechnology Progress. e3354. PMID 37161726 DOI: 10.1002/btpr.3354 |
0.27 |
|
| 2001 |
Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, ... ... Ashkenazi A, et al. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nature Medicine. 7: 383-5. PMID 11283636 DOI: 10.1038/86397 |
0.269 |
|
| 1994 |
Pitti RM, Marsters SA, Haak-Frendscho M, Osaka GC, Mordenti J, Chamow SM, Ashkenazi A. Molecular and biological properties of an interleukin-1 receptor immunoadhesin. Molecular Immunology. 31: 1345-51. PMID 7997246 DOI: 10.1016/0161-5890(94)90053-1 |
0.268 |
|
| 2014 |
Lin BC, Du X, Wang Q, Li H, Ingalla E, Tien J, Rooney I, Ashkenazi A, Penuel E, Qing J. Abstract 3690: MMP-1 and pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer Cancer Research. 74: 3690-3690. DOI: 10.1158/1538-7445.Am2014-3690 |
0.266 |
|
| 2013 |
Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H, Gamache K, Gallagher CM, Ang KK, Wilson C, Okreglak V, Ashkenazi A, Hann B, Nader K, Arkin MR, et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife. 2: e00498. PMID 23741617 DOI: 10.7554/Elife.00498 |
0.266 |
|
| 1994 |
Flasher D, Konopka K, Chamow SM, Dazin P, Ashkenazi A, Pretzer E, Düzgünes N. Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochimica Et Biophysica Acta. 1194: 185-96. PMID 8075135 DOI: 10.1016/0005-2736(94)90219-4 |
0.266 |
|
| 2015 |
Cheah CY, Belada D, Fanale MA, Janikova A, Czucman MS, Flinn IW, Kapp AV, Ashkenazi A, Kelley S, Bray GL, Holden S, Seymour JF. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. The Lancet. Haematology. 2: e166-74. PMID 26687959 DOI: 10.1016/S2352-3026(15)00026-5 |
0.263 |
|
| 1994 |
Chamow SM, Kogan TP, Venuti M, Gadek T, Harris RJ, Peers DH, Mordenti J, Shak S, Ashkenazi A. Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation. Bioconjugate Chemistry. 5: 133-40. PMID 8031876 DOI: 10.1021/Bc00026A005 |
0.263 |
|
| 2014 |
Wilson NS, Duewell P, Yang B, Li Y, Marsters S, Koernig S, Latz E, Maraskovsky E, Morelli AB, Schnurr M, Ashkenazi A. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant. Journal of Immunology (Baltimore, Md. : 1950). 192: 3259-68. PMID 24610009 DOI: 10.4049/Jimmunol.1302011 |
0.262 |
|
| 1987 |
Ashkenazi A, Cohen R, Gertler A. Characterization of lactogen receptors in lactogenic hormone-dependent and independent NB2 lymphoma cell lines. Febs Letters. 210: 51-5. PMID 3803581 DOI: 10.1016/0014-5793(87)81296-6 |
0.26 |
|
| 2014 |
Wilson C, Ye X, Pham T, Lin E, Chan S, McNamara E, Neve RM, Belmont L, Koeppen H, Yauch RL, Ashkenazi A, Settleman J. AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs. Cancer Research. 74: 5878-90. PMID 25125659 DOI: 10.1158/0008-5472.Can-14-1009 |
0.255 |
|
| 1989 |
Lamarre D, Ashkenazi A, Fleury S, Smith DH, Sekaly RP, Capon DJ. The MHC-binding and gp120-binding functions of CD4 are separable. Science (New York, N.Y.). 245: 743-6. PMID 2549633 DOI: 10.1126/Science.2549633 |
0.254 |
|
| 1987 |
Ashkenazi A, Pines M, Gertler A. Down-regulation of lactogenic hormone receptors in Nb2 lymphoma cells by cholera toxin. Biochemistry International. 14: 1065-72. PMID 2839183 |
0.247 |
|
| 2013 |
Wainberg ZA, Messersmith WA, Peddi PF, Kapp AV, Ashkenazi A, Royer-Joo S, Portera CC, Kozloff MF. A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clinical Colorectal Cancer. 12: 248-54. PMID 24075777 DOI: 10.1016/J.Clcc.2013.06.002 |
0.241 |
|
| 2014 |
Du X, Lin BC, Wang QR, Li H, Ingalla E, Tien J, Rooney I, Ashkenazi A, Penuel E, Qing J. MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6324-35. PMID 25326231 DOI: 10.1158/1078-0432.Ccr-13-3336 |
0.241 |
|
| 1999 |
Mori S, Murakami-Mori K, Nakamura S, Ashkenazi A, Bonavida B. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. Journal of Immunology (Baltimore, Md. : 1950). 162: 5616-23. PMID 10228045 |
0.241 |
|
| 1997 |
Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. The Journal of Biological Chemistry. 272: 14029-32. PMID 9162022 DOI: 10.1074/jbc.272.22.14029 |
0.24 |
|
| 1991 |
Ashkenazi A, Smith DH, Marsters SA, Riddle L, Gregory TJ, Ho DD, Capon DJ. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proceedings of the National Academy of Sciences of the United States of America. 88: 7056-60. PMID 1871120 DOI: 10.1073/Pnas.88.16.7056 |
0.236 |
|
| 1987 |
Ashkenazi A, Vogel T, Barash I, Hadari D, Levanon A, Gorecki M, Gertler A. Comparative study of in vitro and in vivo modulation of lactogenic and somatotropic receptors by native human growth hormone and its modified analog prepared by recombinant deoxyribonucleic acid technology. Endocrinology. 121: 414-9. PMID 3595523 DOI: 10.1210/endo-121-1-414 |
0.236 |
|
| 1995 |
Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB. Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. The Journal of Clinical Investigation. 95: 1947-52. PMID 7706502 DOI: 10.1172/Jci117877 |
0.233 |
|
| 1992 |
Marsters SA, Frutkin AD, Simpson NJ, Fendly BM, Ashkenazi A. Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding. The Journal of Biological Chemistry. 267: 5747-50. PMID 1313418 |
0.232 |
|
| 2019 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Auger M, Balasubramanian S, Baller B, Barnes C, Barr G, Bass M, Bay F, Bhat A, Bhattacharya K, et al. Rejecting cosmic background for exclusive charged current quasi elastic neutrino interaction studies with Liquid Argon TPCs; a case study with the MicroBooNE detector European Physical Journal C. 79: 673. DOI: 10.1140/Epjc/S10052-019-7184-7 |
0.231 |
|
| 2020 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Bass M, Bay F, Berkman S, Bhanderi A, et al. Calibration of the charge and energy loss per unit length of the MicroBooNE liquid argon time projection chamber using muons and protons Journal of Instrumentation. 15: P03022-P03022. DOI: 10.1088/1748-0221/15/03/P03022 |
0.228 |
|
| 2011 |
Soria JC, Márk Z, Zatloukal P, Szima B, Albert I, Juhász E, Pujol JL, Kozielski J, Baker N, Smethurst D, Hei YJ, Ashkenazi A, Stern H, Amler L, Pan Y, et al. Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4442-51. PMID 22010015 DOI: 10.1200/Jco.2011.37.2623 |
0.228 |
|
| 2000 |
Kischkel FC, Ashkenazi A. Combining enhanced metabolic labeling with immunoblotting to detect interactions of endogenous cellular proteins. Biotechniques. 29: 506-10, 512. PMID 10997264 DOI: 10.2144/00293St02 |
0.226 |
|
| 1994 |
Haak-Frendscho M, Marsters SA, Mordenti J, Brady S, Gillett NA, Chen SA, Ashkenazi A. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. Journal of Immunology (Baltimore, Md. : 1950). 152: 1347-53. PMID 8301136 |
0.219 |
|
| 2007 |
Xu L, Ashkenazi A, Chaudhuri A. Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells. Angiogenesis. 10: 307-18. PMID 17955335 DOI: 10.1007/s10456-007-9084-y |
0.219 |
|
| 1989 |
Ashkenazi A, Peralta EG, Winslow JW, Ramachandran J, Capon DJ. Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth. Trends in Pharmacological Sciences. 16-22. PMID 2694517 |
0.218 |
|
| 2020 |
Abratenko P, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Berkman S, Bhanderi A, Bhat A, Bishai M, et al. Search for heavy neutral leptons decaying into muon-pion pairs in the MicroBooNE detector Physical Review D. 101: 52001. DOI: 10.1103/Physrevd.101.052001 |
0.217 |
|
| 2020 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Bass M, Bay F, Berkman S, Bhanderi A, et al. Reconstruction and measurement of Journal of Instrumentation. 15: P02007-P02007. DOI: 10.1088/1748-0221/15/02/P02007 |
0.217 |
|
| 2019 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Auger M, Balasubramanian S, Baller B, Barnes C, Barr G, Bass M, Bay F, Bhat A, Bhattacharya K, et al. Design and construction of the MicroBooNE Cosmic Ray Tagger system Journal of Instrumentation. 14: P04004-P04004. DOI: 10.1088/1748-0221/14/04/P04004 |
0.216 |
|
| 2011 |
Salvesen GS, Ashkenazi A. Snapshot: caspases. Cell. 147: 476-476.e1. PMID 22000022 DOI: 10.1016/j.cell.2011.09.030 |
0.214 |
|
| 1986 |
Gertler A, Shamay A, Cohen N, Ashkenazi A, Friesen HG, Levanon A, Gorecki M, Aviv H, Hadary D, Vogel T. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Endocrinology. 118: 720-6. PMID 2417826 DOI: 10.1210/endo-118-2-720 |
0.212 |
|
| 2019 |
Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Auger M, Balasubramanian S, Baller B, Barnes C, Barr G, Bass M, Bay F, Bhat A, Bhattacharya K, Bishai M, et al. First measurement of νμ charged-current π0 production on argon with the MicroBooNE detector Physical Review D. 99: 91102. DOI: 10.1103/Physrevd.99.091102 |
0.21 |
|
| 2000 |
Ashkenazi A, Grewal IS, Dixit VM. Response to 'Secreted IgM versus BLyS in germinal center formation' Nature Immunology. 1: 179. PMID 10973268 DOI: 10.1038/79710 |
0.208 |
|
| 1987 |
Ashkenazi A, Madar Z, Gertler A. Partial purification and characterization of bovine mammary gland prolactin receptor. Molecular and Cellular Endocrinology. 50: 79-87. PMID 3582727 DOI: 10.1016/0303-7207(87)90079-7 |
0.207 |
|
| 2018 |
Duer M, Price JW, Arrington J, Amaryan MJ, Batourine V, Briscoe WJ, Rossi P, Khachatryan M, Niculescu G, Sanctis ED, Nadel-Turonski P, Wei X, Schmidt A, Joo K, Marchand C, ... ... Ashkenazi A, et al. Probing high-momentum protons and neutrons in neutron-rich nuclei Nature. 560: 617-621. PMID 30104596 DOI: 10.1038/S41586-018-0400-Z |
0.207 |
|
| 2000 |
Zhou Q, Fukushima P, DeGraff W, Mitchell JB, Stetler Stevenson M, Ashkenazi A, Steeg PS. Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1. Cancer Research. 60: 2611-5. PMID 10825131 |
0.206 |
|
| 2011 |
Almeida CR, Ashkenazi A, Shahaf G, Kaplan D, Davis DM, Mehr R. Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity. Plos One. 6: e24927. PMID 21949790 DOI: 10.1371/journal.pone.0024927 |
0.206 |
|
| 2022 |
Guttman O, Le Thomas A, Marsters S, Lawrence DA, Gutgesell L, Zuazo-Gaztelu I, Harnoss JM, Haag SM, Murthy A, Strasser G, Modrusan Z, Wu T, Mellman I, Ashkenazi A. Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation. The Journal of Cell Biology. 221. PMID 35446348 DOI: 10.1083/jcb.202111068 |
0.204 |
|
| 2019 |
Abratenko P, Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Auger M, Balasubramanian S, Baller B, Barnes C, Barr G, Bass M, Bay F, Bhat A, et al. First Measurement of Inclusive Muon Neutrino Charged Current Differential Cross Sections on Argon at E_{ν}∼0.8 GeV with the MicroBooNE Detector. Physical Review Letters. 123: 131801. PMID 31697542 DOI: 10.1103/Physrevlett.123.131801 |
0.203 |
|
| 1999 |
Chuntharapai A, Gibbs V, Lu J, Ow A, Marsters S, Ashkenazi A, De Vos A, Jin Kim K. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. Journal of Immunology (Baltimore, Md. : 1950). 163: 766-73. PMID 10395669 |
0.203 |
|
| 1993 |
Barfod ET, Zheng Y, Kuang WJ, Hart MJ, Evans T, Cerione RA, Ashkenazi A. Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. The Journal of Biological Chemistry. 268: 26059-62. PMID 8253717 |
0.2 |
|
| 2009 |
Ashkenazi A, Marks RS. Luminol-dependent chemiluminescence of human phagocyte cell lines: comparison between DMSO differentiated PLB 985 and HL 60 cells. Luminescence : the Journal of Biological and Chemical Luminescence. 24: 171-7. PMID 19291810 DOI: 10.1002/bio.1091 |
0.199 |
|
| 2020 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Bass M, Bay F, Berkman S, Bhanderi A, et al. A method to determine the electric field of liquid argon time projection chambers using a UV laser system and its application in MicroBooNE Journal of Instrumentation. 15: P07010-P07010. DOI: 10.1088/1748-0221/15/07/P07010 |
0.192 |
|
| 2013 |
Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H, Gamache K, Gallagher CM, Ang KK, Wilson C, Okreglak V, Ashkenazi A, Hann B, Nader K, Arkin MR, et al. Author response: Pharmacological brake-release of mRNA translation enhances cognitive memory Elife. DOI: 10.7554/Elife.00498.019 |
0.191 |
|
| 2019 |
Adams C, Alrashed M, An R, Anthony J, Asaadi J, Ashkenazi A, Auger M, Balasubramanian S, Baller B, Barnes C, Barr G, Bass M, Bay F, Bhat A, Bhattacharya K, et al. Deep neural network for pixel-level electromagnetic particle identification in the MicroBooNE liquid argon time projection chamber Physical Review D. 99: 92001. DOI: 10.1103/Physrevd.99.092001 |
0.189 |
|
| 2013 |
Kim JM, Ashkenazi A. Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies. The Journal of Experimental Medicine. 210: 1647-51. PMID 23980122 DOI: 10.1084/jem.20131625 |
0.188 |
|
| 1996 |
Bach EA, Tanner JW, Marsters S, Ashkenazi A, Aguet M, Shaw AS, Schreiber RD. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Molecular and Cellular Biology. 16: 3214-21. PMID 8649432 DOI: 10.1128/Mcb.16.6.3214 |
0.185 |
|
| 1992 |
Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AM, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF. Characterization of the human 5-hydroxytryptamine1B receptor. The Journal of Biological Chemistry. 267: 5735-8. PMID 1348246 |
0.183 |
|
| 2000 |
Halaas O, Vik R, Ashkenazi A, Espevik T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scandinavian Journal of Immunology. 51: 244-50. PMID 10736093 |
0.182 |
|
| 1995 |
Bach EA, Szabo SJ, Dighe AS, Ashkenazi A, Aguet M, Murphy KM, Schreiber RD. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science (New York, N.Y.). 270: 1215-8. PMID 7502050 DOI: 10.1126/Science.270.5239.1215 |
0.179 |
|
| 1994 |
Chamow SM, Zhang DZ, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. Journal of Immunology (Baltimore, Md. : 1950). 153: 4268-80. PMID 7930627 |
0.173 |
|
| 1988 |
Pines M, Ashkenazi A, Cohen-Chapnik N, Binder L, Gertler A. Inhibition of the proliferation of Nb2 cells by femtomolar concentrations of cholera toxin and partial reversal of the effect by 12-O-tetradecanoyl-phorbol-13-acetate. Journal of Cellular Biochemistry. 37: 119-29. PMID 2839525 DOI: 10.1002/jcb.240370111 |
0.168 |
|
| 2013 |
Faingold O, Ashkenazi A, Kaushansky N, Ben-Nun A, Shai Y. An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action. The Journal of Biological Chemistry. 288: 32852-60. PMID 24078631 DOI: 10.1074/Jbc.M113.512038 |
0.168 |
|
| 1992 |
Chamow SM, Kogan TP, Peers DH, Hastings RC, Byrn RA, Ashkenazi A. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent. The Journal of Biological Chemistry. 267: 15916-22. PMID 1639820 |
0.166 |
|
| 2021 |
Levi-Ferber M, Shalash R, Le-Thomas A, Salzberg Y, Shurgi M, Benichou JI, Ashkenazi A, Henis-Korenblit S. Neuronal regulated --dependent mRNA decay controls germline differentiation in . Elife. 10. PMID 34477553 DOI: 10.7554/eLife.65644 |
0.166 |
|
| 2013 |
Ashkenazi A, Faingold O, Kaushansky N, Ben-Nun A, Shai Y. A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice. Blood. 121: 2244-52. PMID 23325839 DOI: 10.1182/Blood-2012-11-468900 |
0.163 |
|
| 1988 |
Peralta EG, Winslow JW, Ashkenazi A, Smith DH, Ramachandran J, Capon DJ. Structural basis of muscarinic acetylcholine receptor subtype diversity. Trends in Pharmacological Sciences. 6-11. PMID 3074539 |
0.162 |
|
| 2022 |
Belyy V, Zuazo-Gaztelu I, Alamban A, Ashkenazi A, Walter P. Endoplasmic reticulum stress activates human IRE1α through reversible assembly of inactive dimers into small oligomers. Elife. 11. PMID 35730415 DOI: 10.7554/eLife.74342 |
0.161 |
|
| 1989 |
Ramachandran J, Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Capon DJ. Structural and functional diversity of muscarinic acetylcholine receptor subtypes. Progress in Clinical and Biological Research. 289: 327-39. PMID 2726804 |
0.16 |
|
| 1998 |
Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. Journal of Immunology (Baltimore, Md. : 1950). 160: 4098-103. PMID 9558121 |
0.16 |
|
| 2020 |
Ferri E, Le Thomas A, Wallweber HA, Day ES, Walters BT, Kaufman SE, Braun MG, Clark KR, Beresini MH, Mortara K, Chen YA, Canter B, Phung W, Liu PS, Lammens A, ... Ashkenazi A, et al. Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands. Nature Communications. 11: 6387. PMID 33318494 DOI: 10.1038/s41467-020-19974-5 |
0.156 |
|
| 1984 |
Gertler A, Ashkenazi A, Madar Z. Binding sites of human growth hormone and ovine and bovine prolactins in the mammary gland and the liver of lactating dairy cow. Molecular and Cellular Endocrinology. 34: 51-7. PMID 6321275 DOI: 10.1016/0303-7207(84)90158-8 |
0.154 |
|
| 2021 |
Le Thomas A, Ferri E, Marsters S, Harnoss JM, Lawrence DA, Zuazo-Gaztelu I, Modrusan Z, Chan S, Solon M, Chalouni C, Li W, Koeppen H, Rudolph J, Wang W, Wu TD, ... ... Ashkenazi A, et al. Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α. Nature Communications. 12: 7310. PMID 34911951 DOI: 10.1038/s41467-021-27597-7 |
0.15 |
|
| 1993 |
Haak-Frendscho M, Marsters SA, Chamow SM, Peers DH, Simpson NJ, Ashkenazi A. Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin. Immunology. 79: 594-9. PMID 8406584 |
0.149 |
|
| 1992 |
Chamow SM, Duliege AM, Ammann A, Kahn JO, Allen JD, Eichberg JW, Byrn RA, Capon DJ, Ward RH, Ashkenazi A. CD4 immunoadhesins in anti-HIV therapy: new developments. International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement. 7: 69-72. PMID 1428410 |
0.147 |
|
| 2020 |
Beveridge RE, Wallweber HA, Ashkenazi A, Beresini M, Clark KR, Gibbons P, Ghiro E, Kaufman S, Larivée A, Leblanc M, Leclerc JP, Lemire A, Ly C, Rudolph J, Schwarz JB, et al. Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory Activity. Acs Medicinal Chemistry Letters. 11: 2389-2396. PMID 33335661 DOI: 10.1021/acsmedchemlett.0c00344 |
0.147 |
|
| 1989 |
Elberg G, Ashkenazi A, Gertler A. Solubilization and characterization of lactogenic hormone receptor from kidney of lactating cow. Molecular and Cellular Endocrinology. 61: 77-85. PMID 2744217 DOI: 10.1016/0303-7207(89)90191-3 |
0.145 |
|
| 2011 |
Ashkenazi A, Viard M, Wexler-Cohen Y, Blumenthal R, Shai Y. Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2156-66. PMID 21429941 DOI: 10.1096/Fj.10-175752 |
0.145 |
|
| 2015 |
Vicinanza M, Korolchuk VI, Ashkenazi A, Puri C, Menzies FM, Clarke JH, Rubinsztein DC. PI(5)P regulates autophagosome biogenesis. Molecular Cell. 57: 219-34. PMID 25578879 DOI: 10.1016/j.molcel.2014.12.007 |
0.144 |
|
| 1996 |
Van Zee KJ, Moldawer LL, Oldenburg HS, Thompson WA, Stackpole SA, Montegut WJ, Rogy MA, Meschter C, Gallati H, Schiller CD, Richter WF, Loetscher H, Ashkenazi A, Chamow SM, Wurm F, et al. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. Journal of Immunology (Baltimore, Md. : 1950). 156: 2221-30. PMID 8690912 |
0.142 |
|
| 2004 |
Ashkenazi A, Silberstein SD. Botulinum toxin and other new approaches to migraine therapy. Annual Review of Medicine. 55: 505-18. PMID 14746533 DOI: 10.1146/annurev.med.55.091902.104440 |
0.137 |
|
| 2013 |
Ashkenazi A, Faingold O, Shai Y. HIV-1 fusion protein exerts complex immunosuppressive effects. Trends in Biochemical Sciences. 38: 345-9. PMID 23685134 DOI: 10.1016/J.Tibs.2013.04.003 |
0.134 |
|
| 2022 |
Cairrão F, Santos CC, Le Thomas A, Marsters S, Ashkenazi A, Domingos PM. Pumilio protects Xbp1 mRNA from regulated Ire1-dependent decay. Nature Communications. 13: 1587. PMID 35332141 DOI: 10.1038/s41467-022-29105-x |
0.131 |
|
| 2010 |
Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y. Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 4196-202. PMID 20605950 DOI: 10.1096/Fj.09-151704 |
0.129 |
|
| 2022 |
Xi Y, LaCanna R, Ma HY, N'Diaye EN, Gierke S, Caplazi P, Sagolla M, Huang Z, Lucio L, Arlantico A, Jeet S, Brightbill H, Emson C, Wong A, Morshead KB, ... ... Ashkenazi A, et al. A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis. Cell Metabolism. PMID 35987202 DOI: 10.1016/j.cmet.2022.07.009 |
0.124 |
|
| 1994 |
Means RT, Krantz SB, Luna J, Marsters SA, Ashkenazi A. Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood. 83: 911-5. PMID 8111063 |
0.12 |
|
| 1992 |
Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. Journal of Virology. 66: 235-43. PMID 1727487 DOI: 10.1128/jvi.66.1.235-243.1992 |
0.12 |
|
| 2022 |
Guidi R, Xu D, Choy DF, Ramalingam TR, Lee WP, Modrusan Z, Liang Y, Marsters S, Ashkenazi A, Huynh A, Mills J, Flanagan S, Hambro S, Nunez V, Leong L, et al. Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma. Science Translational Medicine. 14: eabl8146. PMID 35442706 DOI: 10.1126/scitranslmed.abl8146 |
0.115 |
|
| 2012 |
Ashkenazi A, Viard M, Unger L, Blumenthal R, Shai Y. Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4628-36. PMID 22872679 DOI: 10.1096/Fj.12-215111 |
0.114 |
|
| 2009 |
Ashkenazi A, Abu-Rabeah K, Marks RS. Electrochemistry and chemiluminescence techniques compared in the detection of NADPH oxidase activity in phagocyte cells. Talanta. 77: 1460-5. PMID 19084665 DOI: 10.1016/j.talanta.2008.09.035 |
0.113 |
|
| 2011 |
Ashkenazi A, Wexler-Cohen Y, Shai Y. Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor. Biochimica Et Biophysica Acta. 1808: 2352-8. PMID 21762676 DOI: 10.1016/J.Bbamem.2011.06.020 |
0.111 |
|
| 1977 |
Handzel ZT, Levin S, Ashkenazi A, Hahn T, Altman Y, Czernobilsky B, Shechter B, Trainin N. Immune deficiency of T system with possible T cell regulatory activity defect. Israel Journal of Medical Sciences. 13: 347-53. PMID 194869 |
0.104 |
|
| 2014 |
Klug YA, Ashkenazi A, Viard M, Porat Z, Blumenthal R, Shai Y. Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site. The Biochemical Journal. 461: 213-22. PMID 24766462 DOI: 10.1042/Bj20140189 |
0.096 |
|
| 2013 |
Qiu J, Ashkenazi A, Liu S, Shai Y. Structural and functional properties of the membranotropic HIV-1 glycoprotein gp41 loop region are modulated by its intrinsic hydrophobic core. The Journal of Biological Chemistry. 288: 29143-50. PMID 23960077 DOI: 10.1074/Jbc.M113.496646 |
0.093 |
|
| 1980 |
Ashkenazi A, Levin S, Idar D, Or A, Rosenberg I, Handzel ZT. In vitro cell-mediated immunologic assay for cow's milk allergy. Pediatrics. 66: 399-402. PMID 6999447 |
0.091 |
|
| 2011 |
Ashkenazi A, Shai Y. Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides. European Biophysics Journal : Ebj. 40: 349-57. PMID 21258789 DOI: 10.1007/S00249-010-0666-Z |
0.089 |
|
| 2012 |
Ashkenazi A, Merklinger E, Shai Y. Intramolecular interactions within the human immunodeficiency virus-1 gp41 loop region and their involvement in lipid merging. Biochemistry. 51: 6981-9. PMID 22894130 DOI: 10.1021/Bi300868F |
0.088 |
|
| 1982 |
Ashkenazi A, Levin S, Idar D, Handzel ZT, Altman Y, Or A, Barzilai N. Cellular immunity in children with coeliac disease. European Journal of Pediatrics. 138: 250-3. PMID 6749506 DOI: 10.1007/BF00441211 |
0.087 |
|
| 1981 |
Brautbar C, Freier S, Ashkenazi A, Dekelbaum R, Tur-Kaspa I, Amar A, Cohen I, Sharon R, Abecassis R, Levene C, Cohen T, Albert E. Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens. 17: 313-22. PMID 6947507 |
0.085 |
|
| 1994 |
Tighe MR, Hall MA, Cardi E, Ashkenazi A, Lanchbury JS, Ciclitira PJ. Associations between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility. Human Immunology. 39: 9-16. PMID 8181966 |
0.082 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Measurements of the Nuclear Modification Factor for Jets in Pb+Pb Collisions at √(s)NN]=2.76 TeV with the ATLAS detector. Physical Review Letters. 114: 072302. PMID 25763955 DOI: 10.1103/Physrevlett.114.072302 |
0.081 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, ... ... Ashkenazi A, et al. Constraints on the off-shell Higgs boson signal strength in the high-mass ZZ and WW final states with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 335. PMID 26213488 DOI: 10.1140/Epjc/S10052-015-3542-2 |
0.08 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for new phenomena in final states with an energetic jet and large missing transverse momentum in pp collisions at [Formula: see text]TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 299. PMID 26190936 DOI: 10.1140/Epjc/S10052-015-3517-3 |
0.077 |
|
| 1984 |
Wieser H, Belitz HD, Ashkenazi A. Amino-acid sequence of the coeliac active gliadin peptide B 3142. Zeitschrift Fã¼R Lebensmittel-Untersuchung Und -Forschung. 179: 371-6. PMID 6524078 |
0.075 |
|
| 2004 |
Ashkenazi A, Silberstein SD. Headache management for the pain specialist. Regional Anesthesia and Pain Medicine. 29: 462-75. PMID 15372392 |
0.074 |
|
| 2021 |
Tran NH, Carter SD, De Mazière A, Ashkenazi A, Klumperman J, Walter P, Jensen GJ. The stress-sensing domain of activated IRE1α forms helical filaments in narrow ER membrane tubes. Science (New York, N.Y.). 374: 52-57. PMID 34591618 DOI: 10.1126/science.abh2474 |
0.074 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for the Standard Model Higgs boson produced in association with top quarks and decaying into [Formula: see text] in [Formula: see text] collisions at [Formula: see text] with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 349. PMID 26269691 DOI: 10.1140/Epjc/S10052-015-3543-1 |
0.072 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurements of jet vetoes and azimuthal decorrelations in dijet events produced in [Formula: see text] collisions at [Formula: see text] using the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3117. PMID 25814873 DOI: 10.1140/Epjc/S10052-014-3117-7 |
0.07 |
|
| 2013 |
Ashkenazi A, Blumenfeld A. OnabotulinumtoxinA for the treatment of headache. Headache. 53: 54-61. PMID 24024603 DOI: 10.1111/head.12185 |
0.069 |
|
| 1984 |
Ashkenazi A, Idar D, Maimon M, Hegesh E, Frank E, Hahn T, Wolman Y, Levin S. Alkaline phosphatase activity in fresh intestinal mucosa and cultured mucosal explants. Journal of Pediatric Gastroenterology and Nutrition. 3: 210-4. PMID 6707840 |
0.069 |
|
| 1993 |
Ashkenazi A, Capon DJ, Ward RH. Immunoadhesins. International Reviews of Immunology. 10: 219-27. PMID 7689624 |
0.068 |
|
| 2006 |
Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD. Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia : An International Journal of Headache. 26: 1199-202. PMID 16961786 DOI: 10.1111/j.1468-2982.2006.01191.x |
0.068 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Performance of the ATLAS muon trigger in pp collisions at [Formula: see text] TeV. The European Physical Journal. C, Particles and Fields. 75: 120. PMID 25838797 DOI: 10.1140/Epjc/S10052-015-3325-9 |
0.067 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for dark matter in events with heavy quarks and missing transverse momentum in [Formula: see text] collisions with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 92. PMID 25838796 DOI: 10.1140/Epjc/S10052-015-3306-Z |
0.067 |
|
| 1998 |
Dror Y, Blachar Y, Cohen P, Livni N, Rosenmann E, Ashkenazi A. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 32: 825-8. PMID 9820454 |
0.067 |
|
| 1978 |
Ashkenazi A, Idar D, Handzel ZT, Ofarim M, Levin S. An in-vitro immunological assay for diagnosis of coeliac disease. Lancet. 1: 627-9. PMID 76167 |
0.066 |
|
| 2009 |
Abu-Rabeah K, Ashkenazi A, Atias D, Amir L, Marks RS. Highly sensitive amperometric immunosensor for the detection of Escherichia coli. Biosensors & Bioelectronics. 24: 3461-6. PMID 19501501 DOI: 10.1016/J.Bios.2009.04.042 |
0.065 |
|
| 2009 |
Ashkenazi A, Silberstein S. Is botulinum toxin useful in treating headache? Yes. Current Treatment Options in Neurology. 11: 18-23. PMID 19094832 |
0.065 |
|
| 1979 |
Hahn T, Levin S, Handzel ZT, Ashkenazi A, Chemke J, Shterk V. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome. Israel Journal of Medical Sciences. 15: 775-8. PMID 159876 |
0.064 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, ... ... Ashkenazi A, et al. Measurement of the top quark mass in the [Formula: see text] and [Formula: see text] channels using [Formula: see text] [Formula: see text] ATLAS data. The European Physical Journal. C, Particles and Fields. 75: 330. PMID 26213487 DOI: 10.1140/Epjc/S10052-015-3544-0 |
0.064 |
|
| 2003 |
Ashkenazi A, Laba O, Pishniak L, Figer A. 1262 Evaluation of the results of a multi disciplinary intervention with patients with colorectal cancer European Journal of Cancer Supplements. 1: S383. DOI: 10.1016/S1359-6349(03)91288-2 |
0.063 |
|
| 1987 |
Kohl D, Ashkenazi A, Ben-Shaul Y, Bacher A. Tight junctions of jejunal surface and crypt cells in celiac disease: a freeze-fracture study. Journal of Pediatric Gastroenterology and Nutrition. 6: 57-65. PMID 3794934 |
0.063 |
|
| 2010 |
Ashkenazi A, Blumenfeld A, Napchan U, Narouze S, Grosberg B, Nett R, DePalma T, Rosenthal B, Tepper S, Lipton RB. Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research. Headache. 50: 943-52. PMID 20487039 DOI: 10.1111/j.1526-4610.2010.01675.x |
0.062 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. ATLAS Run 1 searches for direct pair production of third-generation squarks at the Large Hadron Collider. The European Physical Journal. C, Particles and Fields. 75: 510. PMID 26549981 DOI: 10.1140/Epjc/S10052-015-3726-9 |
0.062 |
|
| 1980 |
Ashkenazi A, Levin S, Miskin A. Immunoglobulin levels in children with celiac disease: variations with age and diet. Israel Journal of Medical Sciences. 16: 843-6. PMID 7451111 |
0.061 |
|
| 1979 |
Ashkenazi A, Krasilowsky D, Levin S, Idar D, Kalian M, Or A, Ginat Y, Halperin B. Immunologic reaction of psychotic patients to fractions of gluten. The American Journal of Psychiatry. 136: 1306-9. PMID 384809 |
0.061 |
|
| 2007 |
Ashkenazi A, Silberstein S. Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. Expert Opinion On Pharmacotherapy. 8: 1605-13. PMID 17685879 DOI: 10.1517/14656566.8.11.1605 |
0.06 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for supersymmetry in events containing a same-flavour opposite-sign dilepton pair, jets, and large missing transverse momentum in [Formula: see text] TeV pp collisions with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 318. PMID 26190940 DOI: 10.1140/Epjc/S10052-015-3518-2 |
0.06 |
|
| 1987 |
Cohen R, Ashkenazi A, Elberg G, Gertler A. A comparative study of lactogenic hormone binding sites in the adrenal gland, ovary and kidney of the lactating cow. Journal of Receptor Research. 7: 921-36. PMID 3450875 DOI: 10.3109/10799898709054570 |
0.059 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for scalar diphoton resonances in the mass range 65-600 GeV with the ATLAS detector in pp collision data at √s=8 TeV. Physical Review Letters. 113: 171801. PMID 25379911 DOI: 10.1103/Physrevlett.113.171801 |
0.058 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of three-jet production cross-sections in [Formula: see text] collisions at 7 [Formula: see text] centre-of-mass energy using the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 228. PMID 26041976 DOI: 10.1140/Epjc/S10052-015-3363-3 |
0.058 |
|
| 2007 |
Ashkenazi A, Sholtzow M, Shaw JW, Burstein R, Young WB. Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia : An International Journal of Headache. 27: 111-7. PMID 17257230 DOI: 10.1111/j.1468-2982.2006.01255.x |
0.058 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for invisible decays of the Higgs boson produced in association with a hadronically decaying vector boson in pp collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 337. PMID 26213489 DOI: 10.1140/Epjc/S10052-015-3551-1 |
0.058 |
|
| 1999 |
Ashkenazi A, Freeman S, Argov Z. Effects of cholinergic blockers on auditory brain-stem evoked potentials in rats. Journal of the Neurological Sciences. 164: 124-8. PMID 10402022 |
0.058 |
|
| 2015 |
Robbins MS, Robertson CE, Kaplan E, Ailani J, Charleston L, Kuruvilla D, Blumenfeld A, Berliner R, Rosen NL, Duarte R, Vidwan J, Halker RB, Gill N, Ashkenazi A. The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache. Headache. PMID 26615983 DOI: 10.1111/head.12729 |
0.057 |
|
| 1980 |
Ashkenazi A, Levin S, Idar D, Or A, Rosenberg I, Handzel ZT. Immunological assay for the diagnosis of coeliac disease: interaction between purified gluten fractions. Pediatric Research. 14: 776-8. PMID 6992088 DOI: 10.1203/00006450-198005000-00013 |
0.057 |
|
| 2007 |
Ashkenazi A, Levin M. Greater occipital nerve block for migraine and other headaches: is it useful? Current Pain and Headache Reports. 11: 231-5. PMID 17504651 |
0.057 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of the production and lepton charge asymmetry of [Formula: see text] bosons in Pb+Pb collisions at [Formula: see text] with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 23. PMID 25983646 DOI: 10.1140/Epjc/S10052-014-3231-6 |
0.057 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of the centrality and pseudorapidity dependence of the integrated elliptic flow in lead-lead collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 2982. PMID 25814907 DOI: 10.1140/Epjc/S10052-014-2982-4 |
0.056 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for New Phenomena in Dijet Angular Distributions in Proton-Proton Collisions at sqrt[s]=8 TeV Measured with the ATLAS Detector. Physical Review Letters. 114: 221802. PMID 26196615 DOI: 10.1103/Physrevlett.114.221802 |
0.056 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Evidence of Wγγ Production in pp Collisions at sqrt[s]=8 TeV and Limits on Anomalous Quartic Gauge Couplings with the ATLAS Detector. Physical Review Letters. 115: 031802. PMID 26230784 DOI: 10.1103/Physrevlett.115.031802 |
0.055 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for resonant diboson production in the [Formula: see text] final state in [Formula: see text] collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 69. PMID 25838792 DOI: 10.1140/Epjc/S10052-015-3261-8 |
0.055 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Khalek SA, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for direct top squark pair production in events with a [Formula: see text] boson, [Formula: see text]-jets and missing transverse momentum in [Formula: see text] TeV [Formula: see text] collisions with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 2883. PMID 25814893 DOI: 10.1140/Epjc/S10052-014-2883-6 |
0.055 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Observation and measurements of the production of prompt and non-prompt [Formula: see text] mesons in association with a [Formula: see text] boson in [Formula: see text] collisions at [Formula: see text] with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 229. PMID 26041977 DOI: 10.1140/Epjc/S10052-015-3406-9 |
0.054 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for Higgs boson pair production in the [Formula: see text] final state from pp collisions at [Formula: see text] TeVwith the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 412. PMID 26380565 DOI: 10.1140/Epjc/S10052-015-3628-X |
0.054 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurements of the [Formula: see text] production cross sections in association with jets with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 82. PMID 25838794 DOI: 10.1140/Epjc/S10052-015-3262-7 |
0.053 |
|
| 2013 |
Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, Ailani J, Schim J, Friedman DI, Charleston L, Young WB, Robertson CE, Dodick DW, Silberstein SD, Robbins MS. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review. Headache. 53: 437-46. PMID 23406160 DOI: 10.1111/head.12053 |
0.053 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Two-particle Bose-Einstein correlations in pp collisions at [Formula: see text] 0.9 and 7 TeV measured with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 466. PMID 26457062 DOI: 10.1140/Epjc/S10052-015-3644-X |
0.053 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for Dark Matter in Events with Missing Transverse Momentum and a Higgs Boson Decaying to Two Photons in pp Collisions at sqrt[s]=8 TeV with the ATLAS Detector. Physical Review Letters. 115: 131801. PMID 26451544 DOI: 10.1103/Physrevlett.115.131801 |
0.053 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for Higgs and Z Boson Decays to J/ψγ and ϒ(nS)γ with the ATLAS Detector. Physical Review Letters. 114: 121801. PMID 25860734 DOI: 10.1103/Physrevlett.114.121801 |
0.052 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Measurement of the [Formula: see text] production cross-section using [Formula: see text] events with [Formula: see text]-tagged jets in [Formula: see text] collisions at [Formula: see text] and 8 TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3109. PMID 25814872 DOI: 10.1140/Epjc/S10052-014-3109-7 |
0.052 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for Scalar Charm Quark Pair Production in pp Collisions at sqrt[s]=8 TeV with the ATLAS Detector. Physical Review Letters. 114: 161801. PMID 25955046 DOI: 10.1103/Physrevlett.114.161801 |
0.052 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for direct pair production of a chargino and a neutralino decaying to the 125 GeV Higgs boson in [Formula: see text] TeV [Formula: see text] collisions with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 208. PMID 25995708 DOI: 10.1140/Epjc/S10052-015-3408-7 |
0.051 |
|
| 2004 |
Pishniak L, Ashkenazi A, Sadeh-Tassa D, Yagil Y, Figer A. Depression, anxiety and world assumptions amongst cancer patients Journal of Clinical Oncology. 22: 8197-8197. DOI: 10.1200/JCO.2004.22.90140.8197 |
0.051 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, ... ... Ashkenazi A, et al. Search for metastable heavy charged particles with large ionisation energy loss in pp collisions at [Formula: see text] TeV using the ATLAS experiment. The European Physical Journal. C, Particles and Fields. 75: 407. PMID 26543401 DOI: 10.1140/Epjc/S10052-015-3609-0 |
0.051 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for Higgs boson pair production in the γγbb[over ¯] final state using pp collision data at sqrt[s]=8 TeV from the ATLAS detector. Physical Review Letters. 114: 081802. PMID 25768755 DOI: 10.1103/Physrevlett.114.081802 |
0.051 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for [Formula: see text] decays in [Formula: see text] collisions at [Formula: see text] = 8 TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 165. PMID 25937816 DOI: 10.1140/Epjc/S10052-015-3372-2 |
0.051 |
|
| 2006 |
LoPinto C, Young WB, Ashkenazi A. Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine. Cephalalgia : An International Journal of Headache. 26: 852-6. PMID 16776701 DOI: 10.1111/j.1468-2982.2006.01121.x |
0.051 |
|
| 1998 |
Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Annals of Neurology. 44: 629-34. PMID 9778261 DOI: 10.1002/ana.410440408 |
0.05 |
|
| 2010 |
Ashkenazi A, Yang I, Mushtaq A, Oshinsky ML. Is phonophobia associated with cutaneous allodynia in migraine? Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1256-60. PMID 20562466 DOI: 10.1136/Jnnp.2009.198481 |
0.05 |
|
| 2004 |
Ashkenazi A, Marks LE. Effect of endogenous attention on detection of weak gustatory and olfactory flavors. Perception & Psychophysics. 66: 596-608. PMID 15311659 DOI: 10.3758/Bf03194904 |
0.049 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of the muon reconstruction performance of the ATLAS detector using 2011 and 2012 LHC proton-proton collision data. The European Physical Journal. C, Particles and Fields. 74: 3130. PMID 25814875 DOI: 10.1140/Epjc/S10052-014-3130-X |
0.049 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of distributions sensitive to the underlying event in inclusive Z-boson production in [Formula: see text] collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3195. PMID 25983639 DOI: 10.1140/Epjc/S10052-014-3195-6 |
0.049 |
|
| 1982 |
Wieser H, Springer G, Belitz HD, Ashkenazi A, Idar D. Toxicity of different wheat gliadins in coeliac disease. Zeitschrift Fã¼R Lebensmittel-Untersuchung Und -Forschung. 175: 321-6. PMID 6758408 |
0.048 |
|
| 1979 |
Ashkenazi A, Berrebi A, Levi R, Sakal E, Idar D. Frequency of HLA-B8 in Israeli children with celiac disease. Israel Journal of Medical Sciences. 15: 826-8. PMID 521261 |
0.048 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for heavy long-lived multi-charged particles in pp collisions at [Formula: see text] TeV using the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 362. PMID 26300688 DOI: 10.1140/Epjc/S10052-015-3534-2 |
0.048 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Measurements of the Total and Differential Higgs Boson Production Cross Sections Combining the H→γγ and H→ZZ^{*}→4ℓ Decay Channels at sqrt[s]=8 TeV with the ATLAS Detector. Physical Review Letters. 115: 091801. PMID 26371640 DOI: 10.1103/Physrevlett.115.091801 |
0.048 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for contact interactions and large extra dimensions in the dilepton channel using proton-proton collisions at [Formula: see text] 8 TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3134. PMID 25983635 DOI: 10.1140/Epjc/S10052-014-3134-6 |
0.048 |
|
| 2006 |
Ashkenazi A, Silberstein SD. Hormone-related headache: pathophysiology and treatment. Cns Drugs. 20: 125-41. PMID 16478288 DOI: 10.2165/00023210-200620020-00004 |
0.048 |
|
| 1994 |
Vaisman N, Zadik Z, Akivias A, Voet H, Katz I, Yair S, Ashkenazi A. Changes in body composition, resting energy expenditure, and thermic effect of food in short children on growth hormone therapy. Metabolism: Clinical and Experimental. 43: 1543-8. PMID 7990709 DOI: 10.1016/0026-0495(94)90014-0 |
0.048 |
|
| 2014 |
Aad G, Abajyan T, Abbott B, Abdallah J, Khalek SA, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Electron reconstruction and identification efficiency measurements with the ATLAS detector using the 2011 LHC proton-proton collision data. The European Physical Journal. C, Particles and Fields. 74: 2941. PMID 25814900 DOI: 10.1140/Epjc/S10052-014-2941-0 |
0.047 |
|
| 1983 |
Wieser H, Belitz HD, Ashkenazi A, Idar D. Isolation of coeliac active peptide fractions from gliadin. Zeitschrift Fã¼R Lebensmittel-Untersuchung Und -Forschung. 176: 85-94. PMID 6405556 |
0.047 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. A measurement of the ratio of the production cross sections for [Formula: see text] and [Formula: see text] bosons in association with jets with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3168. PMID 25983636 DOI: 10.1140/Epjc/S10052-014-3168-9 |
0.047 |
|
| 1981 |
Ashkenazi A, Levin S, Idar D. Immunological assays for coeliac disease. Lancet. 2: 687. PMID 6116058 |
0.047 |
|
| 1993 |
Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JS, Ciclitira PJ. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Human Immunology. 38: 270-6. PMID 8138422 |
0.047 |
|
| 1989 |
Sarel R, Miskin A, Ashkenazi A. [Penicillin VK absorption during fasting and after eating]. Harefuah. 117: 430-2. PMID 2516005 |
0.047 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of the top-quark mass in the fully hadronic decay channel from ATLAS data at [Formula: see text]. The European Physical Journal. C, Particles and Fields. 75: 158. PMID 26041974 DOI: 10.1140/Epjc/S10052-015-3373-1 |
0.046 |
|
| 1982 |
Souroujon M, Ashkenazi A, Lupo M, Levin S, Hegesh E. Serum ferritin levels in celiac disease. American Journal of Clinical Pathology. 77: 82-6. PMID 7055099 |
0.046 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Search for invisible particles produced in association with single-top-quarks in proton-proton collisions at [Formula: see text] with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 79. PMID 25838793 DOI: 10.1140/Epjc/S10052-014-3233-4 |
0.046 |
|
| 1986 |
Wieser H, Belitz HD, Idar D, Ashkenazi A. Coeliac activity of the gliadin peptides CT-1 and CT-2. Zeitschrift Fã¼R Lebensmittel-Untersuchung Und -Forschung. 182: 115-7. PMID 3705771 |
0.044 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Light-quark and gluon jet discrimination in [Formula: see text] collisions at [Formula: see text] with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3023. PMID 25814910 DOI: 10.1140/Epjc/S10052-014-3023-Z |
0.044 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, ... ... Ashkenazi A, et al. Measurement of flow harmonics with multi-particle cumulants in Pb+Pb collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 74: 3157. PMID 25814877 DOI: 10.1140/Epjc/S10052-014-3157-Z |
0.044 |
|
| 1993 |
Frydman M, Cohen HA, Ashkenazi A, Varsano I. Familial segregation of cervical ribs, Sprengel anomaly, preaxial polydactyly, anal atresia, and urethral obstruction: a new syndrome? American Journal of Medical Genetics. 45: 717-20. PMID 8456850 DOI: 10.1002/ajmg.1320450611 |
0.044 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for a Heavy Neutral Particle Decaying to eμ, eτ, or μτ in pp Collisions at sqrt[s]=8 TeV with the ATLAS Detector. Physical Review Letters. 115: 031801. PMID 26230783 DOI: 10.1103/Physrevlett.115.031801 |
0.044 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for a new resonance decaying to a W or Z boson and a Higgs boson in the [Formula: see text] final states with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 263. PMID 26097411 DOI: 10.1140/Epjc/S10052-015-3474-X |
0.043 |
|
| 1992 |
Cohen HA, Ashkenazi A, Nussinovitch M, Gross S, Frydman M. Fixed drug eruption of the scrotum due to methylphenidate. The Annals of Pharmacotherapy. 26: 1378-9. PMID 1477441 |
0.043 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Study of the spin and parity of the Higgs boson in diboson decays with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 476. PMID 26472935 DOI: 10.1140/Epjc/S10052-015-3685-1 |
0.041 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, ... ... Ashkenazi A, et al. Determination of spin and parity of the Higgs boson in the [Formula: see text] decay channel with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 231. PMID 26041978 DOI: 10.1140/Epjc/S10052-015-3436-3 |
0.041 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Search for production of [Formula: see text] resonances decaying to a lepton, neutrino and jets in [Formula: see text] collisions at [Formula: see text] TeV with the ATLAS detector. The European Physical Journal. C, Particles and Fields. 75: 209. PMID 25995709 DOI: 10.1140/Epjc/S10052-015-3425-6 |
0.041 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Measurement of spin correlation in top-antitop quark events and search for top squark pair production in pp collisions at √s=8 TeV using the ATLAS detector. Physical Review Letters. 114: 142001. PMID 25910111 DOI: 10.1103/Physrevlett.114.142001 |
0.041 |
|
| 2005 |
Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 45: 350-4. PMID 15836572 DOI: 10.1111/j.1526-4610.2005.05073.x |
0.04 |
|
| 2005 |
Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology. 65: 1419-22. PMID 16275830 DOI: 10.1212/01.wnl.0000183358.53939.38 |
0.04 |
|
| 2009 |
Marmura MJ, Abbas M, Ashkenazi A. Dynamic mechanical (brush) allodynia in cluster headache: a prevalence study in a tertiary headache clinic. The Journal of Headache and Pain. 10: 255-8. PMID 19421708 DOI: 10.1007/s10194-009-0124-4 |
0.039 |
|
| 2014 |
Robbins MS, Kuruvilla D, Blumenfeld A, Charleston L, Sorrell M, Robertson CE, Grosberg BM, Bender SD, Napchan U, Ashkenazi A. Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 54: 1441-59. PMID 25168295 DOI: 10.1111/head.12442 |
0.038 |
|
| 2004 |
Ashkenazi A, Fritz M, Buckley J, Marks LE. The Temporal Automated System for Taste Experiments (TASTE). Behavior Research Methods, Instruments, & Computers : a Journal of the Psychonomic Society, Inc. 36: 83-8. PMID 15190702 DOI: 10.3758/Bf03195552 |
0.038 |
|
| 2008 |
Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 415-7. PMID 17682008 DOI: 10.1136/jnnp.2007.124420 |
0.038 |
|
| 1994 |
Grinbaum A, Ashkenazi A, Avni I, Treister G. Ocular inflammation as an initial manifestation of cutaneous polyarteritis nodosa. The British Journal of Dermatology. 131: 451-2. PMID 7918025 |
0.038 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Identification and energy calibration of hadronically decaying tau leptons with the ATLAS experiment in pp collisions at [Formula: see text][Formula: see text]. The European Physical Journal. C, Particles and Fields. 75: 303. PMID 26190938 DOI: 10.1140/Epjc/S10052-015-3500-Z |
0.038 |
|
| 2010 |
Blumenfeld A, Ashkenazi A, Grosberg B, Napchan U, Narouze S, Nett B, DePalma T, Rosenthal B, Tepper S, Lipton RB. Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS). Headache. 50: 937-42. PMID 20618812 DOI: 10.1111/j.1526-4610.2010.01676.x |
0.037 |
|
| 2009 |
Ashkenazi A, Mushtaq A, Yang I, Oshinsky ML. Ictal and interictal phonophobia in migraine-a quantitative controlled study. Cephalalgia : An International Journal of Headache. 29: 1042-8. PMID 19735532 DOI: 10.1111/J.1468-2982.2008.01834.X |
0.037 |
|
| 2007 |
Ashkenazi A, Silberstein S, Jakubowski M, Burstein R. Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia : An International Journal of Headache. 27: 325-9. PMID 17376108 DOI: 10.1111/j.1468-2982.2007.01291.x |
0.036 |
|
| 2010 |
Ashkenazi A, Blumenfeld A. Response: Peripheral nerve blocks and trigger point injections in headache management: Trigeminal neuralgia does not respond to occipital nerve block Headache. 50: 1216. DOI: 10.1111/j.1526-4610.2010.01726.x |
0.036 |
|
| 2010 |
Zangaladze A, Asadi-Pooya AA, Ashkenazi A, Sperling MR. Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation. Epilepsy & Behavior : E&B. 17: 293-5. PMID 20071244 DOI: 10.1016/j.yebeh.2009.12.017 |
0.036 |
|
| 1981 |
Ashkenazi A, Levin S, Idar D, Or A, Barzilai N, Handzel ZT. Effect of gluten-free diet on an immunological assay for coeliac disease. Lancet. 1: 914-6. PMID 6112326 |
0.034 |
|
| 2007 |
Ashkenazi A, Abbas MA, Sharma DK, Silberstein SD. Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacin. Headache. 47: 127-30. PMID 17355508 DOI: 10.1111/j.1526-4610.2006.00637.x |
0.034 |
|
| 2010 |
Blumenfeld A, Ashkenazi A. Nerve blocks, trigger point injections and headache. Headache. 50: 953-4. PMID 20618813 DOI: 10.1111/j.1526-4610.2010.01685.x |
0.034 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Search for a Charged Higgs Boson Produced in the Vector-Boson Fusion Mode with Decay H(±)→W(±)Z using pp Collisions at √s=8 TeV with the ATLAS Experiment. Physical Review Letters. 114: 231801. PMID 26196792 DOI: 10.1103/Physrevlett.114.231801 |
0.033 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Measurements of four-lepton production at the Z resonance in pp collisions at sqrt[s] = 7 and 8 TeV with ATLAS. Physical Review Letters. 112: 231806. PMID 24972200 DOI: 10.1103/Physrevlett.112.231806 |
0.033 |
|
| 2015 |
Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Ashkenazi A, et al. Combined Measurement of the Higgs Boson Mass in pp Collisions at sqrt[s]=7 and 8 TeV with the ATLAS and CMS Experiments. Physical Review Letters. 114: 191803. PMID 26024162 DOI: 10.1103/Physrevlett.114.191803 |
0.033 |
|
| 1998 |
Cohen O, Steiner I, Argov Z, Ashkenazi A, Diment J, Saada A, River Y. Mitochondrial myopathy with atypical subacute presentation. Journal of Neurology, Neurosurgery, and Psychiatry. 64: 410-1. PMID 9527168 |
0.033 |
|
| 2003 |
Ashkenazi A, Silberstein SD. The evolving management of migraine. Current Opinion in Neurology. 16: 341-5. PMID 12858071 DOI: 10.1097/01.wco.0000073935.19076.47 |
0.032 |
|
| 2016 |
Zhou L, Ashkenazi A, Smith JW, Jen N, Deer TR, Zhou C. Long-Term Clinical Outcome of Peripheral Nerve Stimulation for Chronic Headache and Complication Prevention. Anesthesiology and Pain Medicine. 6: e35983. PMID 27843774 DOI: 10.5812/aapm.35983 |
0.032 |
|
| 2010 |
Zhou L, Hud-Shakoor Z, Hennessey C, Ashkenazi A. Upper cervical facet joint and spinal rami blocks for the treatment of cervicogenic headache. Headache. 50: 657-63. PMID 20132336 DOI: 10.1111/j.1526-4610.2010.01623.x |
0.031 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Evidence for electroweak production of W±W±jj in pp collisions at sqrt[s] = 8 TeV with the ATLAS detector. Physical Review Letters. 113: 141803. PMID 25325632 DOI: 10.1103/Physrevlett.113.141803 |
0.031 |
|
| 2005 |
Davelaar EJ, Goshen-Gottstein Y, Ashkenazi A, Haarmann HJ, Usher M. The demise of short-term memory revisited: empirical and computational investigations of recency effects. Psychological Review. 112: 3-42. PMID 15631586 DOI: 10.1037/0033-295X.112.1.3 |
0.03 |
|
| 2007 |
Zhou L, Ashkenazi A. Poster 203: Cervical C1-2 and C2-3 Facet Joints and Dorsal Rami Injections for the Diagnostic and Therapeutic Tools for Cervicogenic Headache Archives of Physical Medicine and Rehabilitation. 88: E68. DOI: 10.1016/J.APMR.2007.06.614 |
0.03 |
|
| 2008 |
Ashkenazi A, Silberstein S. Botulinum toxin type A for the treatment of headache: why we say yes. Archives of Neurology. 65: 146-9. PMID 18195155 DOI: 10.1001/archneurol.2007.20 |
0.029 |
|
| 2005 |
Ashkenazi A, LoPinto C, Young WB. Referred cutaneous allodynia in a migraine patient without simultaneous headache. Cephalalgia : An International Journal of Headache. 25: 75-8. PMID 15606575 DOI: 10.1111/j.1468-2982.2004.00821.x |
0.029 |
|
| 2013 |
Saar-Dover R, Ashkenazi A, Shai Y. Peptide interaction with and insertion into membranes. Methods in Molecular Biology (Clifton, N.J.). 1033: 173-83. PMID 23996178 DOI: 10.1007/978-1-62703-487-6_12 |
0.029 |
|
| 1993 |
Cohen HA, Nussinovitch M, Ashkenazi A, Straussberg R, Kaushansky A. Benign abducens nerve palsy of childhood. Pediatric Neurology. 9: 394-5. PMID 8292216 |
0.028 |
|
| 1984 |
Dahan S, Slater PE, Cooper M, Brautbar C, Ashkenazi A. Coeliac disease in the Rehovot-Ashdod region of Israel: incidence and ethnic distribution. Journal of Epidemiology and Community Health. 38: 58-60. PMID 6608573 |
0.028 |
|
| 2004 |
Young WB, Mateos V, Ashkenazi A. Occipital nerve block rapidly eliminates allodynia far from the site of headache: a case report. Cephalalgia : An International Journal of Headache. 24: 906-7. PMID 15377325 DOI: 10.1111/j.1468-2982.2004.00779.x |
0.027 |
|
| 1984 |
Ashkenazi A, Frydman M, Weitz R, Lehrer E, Zahavi I. Myocarditis and acute infantile hemiparesis. Case report. Helvetica Paediatrica Acta. 39: 491-5. PMID 6543858 |
0.027 |
|
| 1982 |
Ashkenazi AI. [Late results of surgical treatment of Kienboeck's disease]. Khirurgiia. 43-7. PMID 7176401 |
0.026 |
|
| 2000 |
Cohen HA, Ashkenazi A, Barzilai A, Lahat E. Nocturnal acute laryngospasm in children: a possible epileptic phenomenon. Journal of Child Neurology. 15: 202-4. PMID 10757476 |
0.026 |
|
| 2016 |
Michelle Androulakis X, Krebs KA, Ashkenazi A. Hemicrania continua may respond to repetitive sphenopalatine ganglion block: A case report. Headache. PMID 26926875 DOI: 10.1111/head.12783 |
0.025 |
|
| 1983 |
Zlotogora J, Ben Ezra D, Livni N, Ashkenazi A, Cohen T. A muscle disorder as presenting symptom in a child with mucolipidosis IV. Neuropediatrics. 14: 104-5. PMID 6877526 DOI: 10.1055/s-2008-1059563 |
0.025 |
|
| 2010 |
Hud-Shakoor Z, Hennessey C, Ashkenazi A, Zhou L. Poster 272: Upper Cervical Facet Joint and Spinal Rami Blocks for Treatment of Cervicogenic Headache Pm&R. 2: S122-S123. DOI: 10.1016/j.pmrj.2010.07.306 |
0.024 |
|
| 2004 |
Ashkenazi A, Levin M. Three common neuralgias. How to manage trigeminal, occipital, and postherpetic pain. Postgraduate Medicine. 116: 16-8, 21-4, 31-2 pas. PMID 15460087 DOI: 10.3810/pgm.2004.09.1579 |
0.024 |
|
| 1978 |
Ashkenazi AI, Arenberg AA, Korolev AP. [Surgical treatment of Dupuytren's contracture by the method of "open palm and fingers"]. Khirurgiia. 22-7. PMID 732108 |
0.024 |
|
| 2015 |
Blumenfeld A, Ashkenazi A, Evans RW. Occipital and trigeminal nerve blocks for migraine. Headache. 55: 682-9. PMID 25918869 DOI: 10.1111/head.12579 |
0.022 |
|
| 1999 |
Ashkenazi A, Ovadia H, Abramsky O. [Paraneoplastic autoimmune syndromes of the nervous system]. Harefuah. 137: 394-9. PMID 11419044 |
0.022 |
|
| 2014 |
Aad G, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O, Aben R, Abi B, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, ... ... Ashkenazi A, et al. Observation of an excited Bc(±) meson state with the ATLAS detector. Physical Review Letters. 113: 212004. PMID 25479491 DOI: 10.1103/Physrevlett.113.212004 |
0.021 |
|
| 1992 |
Cohen HA, Ashkenazi A, Nussinovitch M, Amir J, Hart J, Frydman M. Mumps-associated acute cerebellar ataxia. American Journal of Diseases of Children (1960). 146: 930-1. PMID 1636659 |
0.021 |
|
| 2008 |
Zhou L, Abramov R, Ashkenazi A. Poster 268: The Role of Cervical C1/2, C2/3 Spinal Injections in the Diagnosis of Cervicogenic Headache Archives of Physical Medicine and Rehabilitation. 89: e106. DOI: 10.1016/J.APMR.2008.09.268 |
0.02 |
|
| 2009 |
Ashkenazi A. The association between migraine and cardiovascular events in women is modified by baseline vascular risk status Current Pain and Headache Reports. 13: 181-182. DOI: 10.1007/S11916-009-0031-Z |
0.02 |
|
| 1988 |
Leibovitz E, Ashkenazi A, Levin S, Nissim F. Fatal pericardial tamponade complicating total parenteral nutrition via a silastic central vein catheter. Journal of Pediatric Gastroenterology and Nutrition. 7: 306-7. PMID 3127571 |
0.02 |
|
| 1993 |
Vandenplas Y, Ashkenazi A, Belli D, Boige N, Bouquet J, Cadranel S, Cezard JP, Cucchiara S, Dupont C, Geboes K. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN). European Journal of Pediatrics. 152: 704-11. PMID 8223796 |
0.019 |
|
| 2004 |
Ashkenazi A, Young WB. Dynamic mechanical (brush) allodynia in cluster headache. Headache. 44: 1010-2. PMID 15546264 DOI: 10.1111/j.1526-4610.2004.04195.x |
0.019 |
|
| 2010 |
Zhou L, Abad M, Ashkenazi A, Hud-Shakoor ZR. Poster 264: Occipital and Supraorbital Nerve Stimulation for Refractory Cervicogenic Headache- A Comparative Study Pm&R. 2: S119-S119. DOI: 10.1016/j.pmrj.2010.07.298 |
0.017 |
|
| 2007 |
Dinkevich I, Ashkenazi A, Inbar M. 8133 POSTER Alternative treatments to an oncology department staff European Journal of Cancer Supplements. 5: 447. DOI: 10.1016/S1359-6349(07)71635-X |
0.016 |
|
| 2012 |
Lew B, Stief P, Beliavski M, Ashkenazi A, Svitlica O, Khan A, Tarre S, de Beer D, Green M. Characterization of denitrifying granular sludge with and without the addition of external carbon source. Bioresource Technology. 124: 413-20. PMID 23010209 DOI: 10.1016/j.biortech.2012.08.049 |
0.015 |
|
| 1969 |
Glazer I, Ashkenazi A, Magora F. Electrosleep therapy in bronchial asthma. International Archives of Allergy and Applied Immunology. 36: 163-71. PMID 5809811 DOI: 10.1159/000230737 |
0.015 |
|
| 2011 |
Ashkenazi A, Schwedt T. Cluster headache--acute and prophylactic therapy. Headache. 51: 272-86. PMID 21284609 DOI: 10.1111/j.1526-4610.2010.01830.x |
0.015 |
|
| 1990 |
Ashkenazi A. [Celiac disease where to? An update]. Harefuah. 118: 167-72. PMID 2187772 |
0.014 |
|
| 2008 |
Ashkenazi A, Brown F. Images from headache: cluster-like headache associated with intra-cavernous carotid artery thrombosis. Headache. 48: 1214-5. PMID 18808501 DOI: 10.1111/j.1526-4610.2008.01225.x |
0.013 |
|
| 2004 |
Ashkenazi A, Silberstein SD. Periodic autonomic dysfunction without pain in a patient with cluster headache. Cephalalgia : An International Journal of Headache. 24: 1005-6. PMID 15482367 DOI: 10.1111/j.1468-2982.2004.00794.x |
0.012 |
|
| 2008 |
Young WB, Marmura M, Ashkenazi A, Evans RW. Expert opinion: greater occipital nerve and other anesthetic injections for primary headache disorders. Headache. 48: 1122-5. PMID 18687084 DOI: 10.1111/j.1526-4610.2008.01192.x |
0.012 |
|
| 1992 |
Ashkenazi A, Cooper M, Chemke J, Simon D, Cohen C, Mass N, Schattner A. The quality assurance committee in a general hospital: its use in improvement of the medical record. Israel Journal of Medical Sciences. 28: 714-7. PMID 1399501 |
0.012 |
|
| 1980 |
Ashkenazi A, Levin S, Krasilowsky D. Gluten and autism. Lancet. 1: 157. PMID 6101497 |
0.011 |
|
| 1983 |
Ashkenazi A, Cooper M, Nissim F, Dahan S, Garti R, Levin S. Occurrence of celiac disease in children in a defined area of Israel. Israel Journal of Medical Sciences. 19: 63-6. PMID 6832950 |
0.011 |
|
| 2009 |
Ashkenazi A. The role of botulinum neurotoxin in pain management--an ongoing controversy. Current Pain and Headache Reports. 13: 249-52. PMID 19586585 |
0.011 |
|
| 1993 |
Dror Y, Ashkenazi A. [Risk of HIV infection among health care workers]. Harefuah. 124: 151-4. PMID 8495884 |
0.011 |
|
| 2011 |
Pello SJ, Ashkenazi A. Spinal cord infarction in a woman with cardiac fibroelastoma. The Neurologist. 17: 47-8. PMID 21192195 DOI: 10.1097/NRL.0b013e3181d2a956 |
0.01 |
|
| 2010 |
Ashkenazi A. Botulinum toxin type a for chronic migraine. Current Neurology and Neuroscience Reports. 10: 140-6. PMID 20425239 DOI: 10.1007/s11910-010-0087-5 |
0.01 |
|
| 2010 |
Ashkenazi A. Allodynia in cluster headache. Current Pain and Headache Reports. 14: 140-4. PMID 20425203 DOI: 10.1007/s11916-010-0097-7 |
0.01 |
|
| 2007 |
Pizzi L, Lee S, Richardson D, Cobb N, Leas B, Toner R, Pracilio V, Bailas S, Ashkenazi A, Derk C, Wang D, DeSousa E. PPN9 PERCEPTION OF BREAKTHROUGH PAIN IN PATIENTS WITH CHRONIC PAINFUL CONDITIONS Value in Health. 10: A466. DOI: 10.1016/S1098-3015(10)65604-5 |
0.01 |
|
| 2007 |
Pizzi L, Lee S, Richardson D, Cobb N, Leas B, Toner R, Pracilio V, Bailas S, Ashkenazi A, Derk C, Wang D, DeSousa E. PPN7 RESOURCE UTILIZATION DUE TO BREAKTHROUGH PAIN: RESULTS FROM A PROSPECTIVE STUDY ON PATIENTS WITH CHRONIC PAINFUL CONDITIONS Value in Health. 10: A465-A466. DOI: 10.1016/S1098-3015(10)65602-1 |
0.01 |
|
| 2000 |
Ashkenazi A, Kaufman Y, Ben-Hur T. Bilateral focal motor status epilepticus with retained consciousness after stroke. Neurology. 54: 976-8. PMID 10690997 |
0.01 |
|
| 1997 |
Sever Y, Ashkenazi A, Tyano S, Weizman A. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology. 35: 178-80. PMID 9246217 |
0.01 |
|
| 1993 |
Ashkenazi A. The LIF test. Acta Paediatrica (Oslo, Norway : 1992). 82: 260. PMID 8495080 |
0.01 |
|
| 1986 |
Ashkenazi A, Zaizov R, Matoth Y. Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease. European Journal of Pediatrics. 145: 138-41. PMID 3732318 |
0.01 |
|
| 1985 |
Dick J, Ashkenazi A, Chamke M. [Oculo-cerebro-renal syndrome in a newborn]. Harefuah. 108: 592-3. PMID 4065726 |
0.01 |
|
| 1984 |
Ashkenazi AI. [Traumatic arthritis of the wrist joint]. Khirurgiia. 58-62. PMID 6700172 |
0.01 |
|
| 1984 |
Ashkenazi AI, Lipkin SI. [So-called "calcium gout"]. Khirurgiia. 107-11. PMID 6521289 |
0.01 |
|
| Hide low-probability matches. |